{"name":"GlaxoSmithKline","slug":"glaxosmithkline","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1200000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Benlysta","genericName":"Benlysta","slug":"benlysta","revenue":1200000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"1994-01-01","label":"Salmeterol 50 mcg via DISKUS first approved","drug":"Salmeterol 50 mcg via DISKUS","drugSlug":"salmeterol-50-mcg-via-diskus","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Exdensur first approved","drug":"Exdensur","drugSlug":"depemokimab","type":"approval","sentiment":"positive"},{"date":"2025-01-01","label":"Blujepa first approved","drug":"Blujepa","drugSlug":"gepotidacin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-02-01","label":"Capoten Phase 3 readout (Community-acquired Pneumonia, Influenza, COVID-19)","drug":"Capoten","drugSlug":"capoten","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":1200000000,"percentOfTotal":100,"drugCount":32,"colorKey":"oncology","drugs":[{"name":"Benlysta","genericName":"Benlysta","slug":"benlysta","indication":"Systemic lupus erythematosus","status":"marketed","revenue":1200000000},{"name":"Boostrix Polio™ 711866","genericName":"Boostrix Polio™ 711866","slug":"boostrix-polio-711866","indication":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults","status":"phase_3"},{"name":"Boostrix ® Polio","genericName":"Boostrix ® Polio","slug":"boostrix-polio","indication":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults","status":"marketed"},{"name":"BoostrixTM Polio","genericName":"BoostrixTM Polio","slug":"boostrixtm-polio","indication":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults","status":"marketed"},{"name":"GSK Biologicals' DTPa-IPV/Hib vaccine","genericName":"GSK Biologicals' DTPa-IPV/Hib vaccine","slug":"gsk-biologicals-dtpa-ipv-hib-vaccine","indication":"Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"GSK3389404","genericName":"GSK3389404","slug":"gsk3389404","indication":"Psoriasis","status":"phase_2"},{"name":"GW685698","genericName":"GW685698","slug":"gw685698","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"Infanrix Hib™","genericName":"Infanrix Hib™","slug":"infanrix-hib","indication":"Primary immunization against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"Infanrix IPV","genericName":"Infanrix IPV","slug":"infanrix-ipv","indication":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in infants and children","status":"marketed"},{"name":"Infanrix® Penta","genericName":"Infanrix® Penta","slug":"infanrix-penta","indication":"Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"marketed"},{"name":"Marketed varicella vaccine_Lot 1","genericName":"Marketed varicella vaccine_Lot 1","slug":"marketed-varicella-vaccine-lot-1","indication":"Prevention of varicella (chickenpox) in children and adults","status":"phase_3"},{"name":"RSVPreF3 OA vaccine","genericName":"RSVPreF3 OA vaccine","slug":"rsvpref3-oa-vaccine","indication":"Prevention of respiratory syncytial virus (RSV) disease in older adults (≥60 years)","status":"phase_3"},{"name":"VI","genericName":"VI","slug":"vi","indication":"Prevention of herpes zoster (shingles) in adults aged 50 years and older","status":"marketed"},{"name":"Alclometasone dipropionate cream","genericName":"Alclometasone dipropionate cream","slug":"alclometasone-dipropionate-cream","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)","status":"phase_2"},{"name":"Belimumab (GSK1550188)","genericName":"Belimumab (GSK1550188)","slug":"belimumab-gsk1550188","indication":"Systemic lupus erythematosus (SLE) with active disease","status":"marketed"},{"name":"Betamethasone valerate 0.1%","genericName":"Betamethasone valerate 0.1%","slug":"betamethasone-valerate-0-1","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)","status":"phase_3"},{"name":"Boostrix PolioTM","genericName":"Boostrix PolioTM","slug":"boostrix-poliotm","indication":"Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults","status":"phase_3"},{"name":"Boostrix TM","genericName":"Boostrix TM","slug":"boostrix-tm","indication":"Booster vaccination against diphtheria, tetanus, and pertussis in adolescents (10 years and older) and adults","status":"marketed"},{"name":"Boostrix™-US formulation","genericName":"Boostrix™-US formulation","slug":"boostrix-us-formulation","indication":"Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults aged 10 years and older","status":"marketed"},{"name":"Clobetasone Butyrate 0.05% Cream","genericName":"Clobetasone Butyrate 0.05% Cream","slug":"clobetasone-butyrate-0-05-cream","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)","status":"phase_3"},{"name":"DTPa-HBV-IPV (Infanrix penta™)","genericName":"DTPa-HBV-IPV (Infanrix penta™)","slug":"dtpa-hbv-ipv-infanrix-penta","indication":"Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and poliomyelitis in infants and children","status":"phase_3"},{"name":"DTPa-HBV-IPV/Hib","genericName":"DTPa-HBV-IPV/Hib","slug":"dtpa-hbv-ipv-hib","indication":"Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"marketed"},{"name":"DTPa-HBV-IPV/Hib vaccine","genericName":"DTPa-HBV-IPV/Hib vaccine","slug":"dtpa-hbv-ipv-hib-vaccine","indication":"Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"DTPa-IPV","genericName":"DTPa-IPV","slug":"dtpa-ipv","indication":"Primary immunization against diphtheria, tetanus, pertussis, and poliomyelitis in infants and children","status":"phase_3"},{"name":"DTPa-IPV/Hib vaccine","genericName":"DTPa-IPV/Hib vaccine","slug":"dtpa-ipv-hib-vaccine","indication":"Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"DTPw-HBV/Hib","genericName":"DTPw-HBV/Hib","slug":"dtpw-hbv-hib","indication":"Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"DTPw-HBV/Hib Kft vaccine GSK323527A","genericName":"DTPw-HBV/Hib Kft vaccine GSK323527A","slug":"dtpw-hbv-hib-kft-vaccine-gsk323527a","indication":"Active immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and young children","status":"phase_3"},{"name":"DTaP5-HBV-IPV-Hib","genericName":"DTaP5-HBV-IPV-Hib","slug":"dtap5-hbv-ipv-hib","indication":"Active immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children","status":"marketed"},{"name":"Decavac™","genericName":"Decavac™","slug":"decavac","indication":"Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults","status":"phase_3"},{"name":"Diclofenac diethylamine 2.32% gel","genericName":"Diclofenac diethylamine 2.32% gel","slug":"diclofenac-diethylamine-2-32-gel","indication":"Topical treatment of localized pain and inflammation associated with musculoskeletal conditions (e.g., sprains, strains, osteoarthritis)","status":"phase_3"},{"name":"Eltrombopag oral tablets","genericName":"Eltrombopag oral tablets","slug":"eltrombopag-oral-tablets","indication":"Chronic immune thrombocytopenia (ITP)","status":"phase_3"},{"name":"Engerix-B Kinder","genericName":"Engerix-B Kinder","slug":"engerix-b-kinder","indication":"Active immunization against hepatitis B infection in infants and children","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":148,"colorKey":"neuroscience","drugs":[{"name":"ADOAIR250","genericName":"ADOAIR250","slug":"adoair250","indication":"Other","status":"marketed"},{"name":"AS03B","genericName":"AS03B","slug":"as03b","indication":"Other","status":"phase_2"},{"name":"ASP3772","genericName":"ASP3772","slug":"asp3772","indication":"Other","status":"phase_1"},{"name":"ActHIB®","genericName":"ActHIB®","slug":"acthib","indication":"Prevention of invasive disease caused by Haemophilus influenzae type b in infants and children","status":"marketed"},{"name":"Additional challenge dose","genericName":"Additional challenge dose","slug":"additional-challenge-dose","indication":"Influenza","status":"marketed"},{"name":"Amine Fluoride Toothpaste","genericName":"Amine Fluoride Toothpaste","slug":"amine-fluoride-toothpaste","indication":"Prevention of dental caries (cavities)","status":"phase_3"},{"name":"Anticancer therapy 4","genericName":"Anticancer therapy 4","slug":"anticancer-therapy-4","indication":"Other","status":"phase_1"},{"name":"Arepanrix®","genericName":"Arepanrix®","slug":"arepanrix","indication":"Other","status":"marketed"},{"name":"Cervarix","genericName":"Cervarix","slug":"cervarix","indication":"Other","status":"marketed"},{"name":"Cherry lamotrigine ODT","genericName":"Cherry lamotrigine ODT","slug":"cherry-lamotrigine-odt","indication":"Other","status":"phase_1"},{"name":"FF ELLIPTA DPI","genericName":"FF ELLIPTA DPI","slug":"ff-ellipta-dpi","indication":"Other","status":"phase_1"},{"name":"FLU-QIV","genericName":"FLU-QIV","slug":"flu-qiv","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"FP","genericName":"FP","slug":"fp","indication":"Other","status":"marketed"},{"name":"FP 250mcg","genericName":"FP 250mcg","slug":"fp-250mcg","indication":"Other","status":"marketed"},{"name":"FPNS","genericName":"FPNS","slug":"fpns","indication":"Other","status":"marketed"},{"name":"Firategrast modified release tablet","genericName":"Firategrast modified release tablet","slug":"firategrast-modified-release-tablet","indication":"Other","status":"phase_1"},{"name":"Fluarix-AS25","genericName":"Fluarix-AS25","slug":"fluarix-as25","indication":"Protection against influenza disease caused by the AS25 strain of the influenza virus","status":"phase_2"},{"name":"FluarixTM","genericName":"FluarixTM","slug":"fluarixtm","indication":"Seasonal influenza prevention in adults and children ≥6 months of age","status":"marketed"},{"name":"Fluarix™ VB","genericName":"Fluarix™ VB","slug":"fluarix-vb","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"GR205171","genericName":"GR205171","slug":"gr205171","indication":"Other","status":"phase_2"},{"name":"GS856553","genericName":"GS856553","slug":"gs856553","indication":"Other","status":"phase_2"},{"name":"GSK investigational vaccine GSK1557482A","genericName":"GSK investigational vaccine GSK1557482A","slug":"gsk-investigational-vaccine-gsk1557482a","indication":"Investigational indication under phase 3 evaluation (specific indication not publicly confirmed)","status":"phase_3"},{"name":"GSK1325756","genericName":"GSK1325756","slug":"gsk1325756","indication":"Other","status":"phase_1"},{"name":"GSK1362885","genericName":"GSK1362885","slug":"gsk1362885","indication":"Other","status":"phase_1"},{"name":"GSK1399686","genericName":"GSK1399686","slug":"gsk1399686","indication":"Other","status":"phase_2"},{"name":"GSK2890457","genericName":"GSK2890457","slug":"gsk2890457","indication":"Other","status":"phase_2"},{"name":"GSK3036656","genericName":"GSK3036656","slug":"gsk3036656","indication":"Other","status":"phase_2"},{"name":"GSK364735","genericName":"GSK364735","slug":"gsk364735","indication":"Other","status":"phase_2"},{"name":"GW677954","genericName":"GW677954","slug":"gw677954","indication":"Other","status":"phase_2"},{"name":"GW810781","genericName":"GW810781","slug":"gw810781","indication":"Other","status":"phase_2"},{"name":"GW842166","genericName":"GW842166","slug":"gw842166","indication":"Other","status":"phase_2"},{"name":"GW856553","genericName":"GW856553","slug":"gw856553","indication":"Other","status":"phase_2"},{"name":"HAVRIX","genericName":"HAVRIX","slug":"havrix","indication":"Other","status":"marketed"},{"name":"Infanrix TM","genericName":"Infanrix TM","slug":"infanrix-tm","indication":"Prevention of diphtheria, tetanus, and pertussis in infants and children (primary series and boosters)","status":"marketed"},{"name":"Investigational varicella vaccine_Lot 2","genericName":"Investigational varicella vaccine_Lot 2","slug":"investigational-varicella-vaccine-lot-2","indication":"Prevention of varicella (chickenpox) in pediatric and adult populations","status":"phase_3"},{"name":"Mencevax™ ACW","genericName":"Mencevax™ ACW","slug":"mencevax-acw","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y","status":"phase_3"},{"name":"Menitorix","genericName":"Menitorix","slug":"menitorix","indication":"Other","status":"marketed"},{"name":"MenitorixTM","genericName":"MenitorixTM","slug":"menitorixtm","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in infants, children, adolescents, and adults","status":"phase_3"},{"name":"Merck and Company's Varivax","genericName":"Merck and Company's Varivax","slug":"merck-and-company-s-varivax","indication":"Prevention of varicella (chickenpox) in children and adults","status":"phase_3"},{"name":"Nicotine (4 mg)","genericName":"Nicotine (4 mg)","slug":"nicotine-4-mg","indication":"Smoking cessation aid","status":"marketed"},{"name":"Nicotine Lozenges","genericName":"Nicotine Lozenges","slug":"nicotine-lozenges","indication":"Smoking cessation","status":"phase_3"},{"name":"Paracetamol formulation 4","genericName":"Paracetamol formulation 4","slug":"paracetamol-formulation-4","indication":"Other","status":"phase_1"},{"name":"Paracetamol medium dissolution suspension","genericName":"Paracetamol medium dissolution suspension","slug":"paracetamol-medium-dissolution-suspension","indication":"Other","status":"phase_1"},{"name":"Part A","genericName":"Part A","slug":"part-a","indication":"Other","status":"marketed"},{"name":"Part B","genericName":"Part B","slug":"part-b","indication":"Other","status":"marketed"},{"name":"Polio Sabin","genericName":"Polio Sabin","slug":"polio-sabin","indication":"Polio prevention","status":"phase_3"},{"name":"Poliorix TM","genericName":"Poliorix TM","slug":"poliorix-tm","indication":"Other","status":"marketed"},{"name":"Prevenar 13","genericName":"Prevenar 13","slug":"prevenar-13","indication":"Other","status":"marketed"},{"name":"Priorix","genericName":"Priorix","slug":"priorix","indication":"Other","status":"marketed"},{"name":"PriorixTetra™","genericName":"PriorixTetra™","slug":"priorixtetra","indication":"Measles, mumps, rubella, and varicella prevention in individuals 9 months of age and older","status":"phase_3"},{"name":"RSV F subunit 45 μg MF59 adjuvant","genericName":"RSV F subunit 45 μg MF59 adjuvant","slug":"rsv-f-subunit-45-g-mf59-adjuvant","indication":"Other","status":"phase_1"},{"name":"RSV F subunit 45 μg No adjuvant","genericName":"RSV F subunit 45 μg No adjuvant","slug":"rsv-f-subunit-45-g-no-adjuvant","indication":"Other","status":"phase_1"},{"name":"Rabipur","genericName":"Rabipur","slug":"rabipur","indication":"Other","status":"marketed"},{"name":"RepevaxTM","genericName":"RepevaxTM","slug":"repevaxtm","indication":"Booster vaccination against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults","status":"phase_3"},{"name":"Rotarix TM","genericName":"Rotarix TM","slug":"rotarix-tm","indication":"Prevention of rotavirus gastroenteritis in infants and young children","status":"marketed"},{"name":"Routine Treatment","genericName":"Routine Treatment","slug":"routine-treatment","indication":"Other","status":"marketed"},{"name":"SB-659032","genericName":"SB-659032","slug":"sb-659032","indication":"Other","status":"phase_1"},{"name":"Salmeterol 50 mcg via DISKUS","genericName":"Salmeterol 50 mcg via DISKUS","slug":"salmeterol-50-mcg-via-diskus","indication":"Other","status":"marketed"},{"name":"Sodium Fluoride (NaF)","genericName":"Sodium Fluoride (NaF)","slug":"sodium-fluoride-naf","indication":"Osteoporosis treatment and prevention","status":"phase_3"},{"name":"Squarekids","genericName":"Squarekids","slug":"squarekids","indication":"Other","status":"marketed"},{"name":"Standard therapy","genericName":"Standard therapy","slug":"standard-therapy","indication":"Other","status":"marketed"},{"name":"Synflorix","genericName":"Synflorix","slug":"synflorix","indication":"Other","status":"marketed"},{"name":"Test 2 Montelukast","genericName":"Test 2 Montelukast","slug":"test-2-montelukast","indication":"Other","status":"phase_1"},{"name":"Varivax","genericName":"Varivax","slug":"varivax","indication":"Other","status":"marketed"},{"name":"Vaxneuvance","genericName":"Vaxneuvance","slug":"vaxneuvance","indication":"Other","status":"marketed"},{"name":"ropinirole monotherapy","genericName":"ropinirole monotherapy","slug":"ropinirole-monotherapy","indication":"Other","status":"marketed"},{"name":"rosiglitazone-metformin fixed dose combination","genericName":"rosiglitazone-metformin fixed dose combination","slug":"rosiglitazone-metformin-fixed-dose-combination","indication":"Other","status":"marketed"},{"name":"14C-SB649868","genericName":"14C-SB649868","slug":"14c-sb649868","indication":"Other","status":"phase_1"},{"name":"3% Benzoyl Peroxide","genericName":"3% Benzoyl Peroxide","slug":"3-benzoyl-peroxide","indication":"Other","status":"marketed"},{"name":"3% Menthol","genericName":"3% Menthol","slug":"3-menthol","indication":"Other","status":"marketed"},{"name":"5% Potassium nitrate","genericName":"5% Potassium nitrate","slug":"5-potassium-nitrate","indication":"Other","status":"marketed"},{"name":"89Zr-GSK2849330","genericName":"89Zr-GSK2849330","slug":"89zr-gsk2849330","indication":"Other","status":"phase_1"},{"name":"89Zr-GSK3128349 1 mg","genericName":"89Zr-GSK3128349 1 mg","slug":"89zr-gsk3128349-1-mg","indication":"Other","status":"phase_1"},{"name":"AAAA","genericName":"AAAA","slug":"aaaa","indication":"Unknown","status":"phase_3"},{"name":"AB","genericName":"AB","slug":"ab","indication":"Other","status":"marketed"},{"name":"ADA 0.1% gel","genericName":"ADA 0.1% gel","slug":"ada-0-1-gel","indication":"Other","status":"marketed"},{"name":"AS03A","genericName":"AS03A","slug":"as03a","indication":"Other","status":"phase_2"},{"name":"Acetylcysteine 2% solution","genericName":"Acetylcysteine 2% solution","slug":"acetylcysteine-2-solution","indication":"Treatment of acetaminophen overdose","status":"phase_1"},{"name":"Acetylcystine","genericName":"Acetylcystine","slug":"acetylcystine","indication":"Other","status":"phase_3"},{"name":"Adalimumab, solution for injection","genericName":"Adalimumab, solution for injection","slug":"adalimumab-solution-for-injection","indication":"Other","status":"phase_1"},{"name":"Adjuvanted pandemic influenza candidate vaccine","genericName":"Adjuvanted pandemic influenza candidate vaccine","slug":"adjuvanted-pandemic-influenza-candidate-vaccine","indication":"Pandemic influenza prevention in adults","status":"phase_3"},{"name":"Afuresertib GC - Fasted State","genericName":"Afuresertib GC - Fasted State","slug":"afuresertib-gc-fasted-state","indication":"Other","status":"phase_1"},{"name":"Afuresertib GC - Fed State","genericName":"Afuresertib GC - Fed State","slug":"afuresertib-gc-fed-state","indication":"Other","status":"phase_1"},{"name":"Afuresertib HPMC capsule - Fasted State","genericName":"Afuresertib HPMC capsule - Fasted State","slug":"afuresertib-hpmc-capsule-fasted-state","indication":"Other","status":"phase_1"},{"name":"Afuresertib HPMC capsule - Fed State","genericName":"Afuresertib HPMC capsule - Fed State","slug":"afuresertib-hpmc-capsule-fed-state","indication":"Other","status":"phase_1"},{"name":"Aimmugen™","genericName":"Aimmugen™","slug":"aimmugen","indication":"Other","status":"phase_2"},{"name":"Albiglutide 50 mg","genericName":"Albiglutide 50 mg","slug":"albiglutide-50-mg","indication":"Other","status":"marketed"},{"name":"Albiglutide 50mg","genericName":"Albiglutide 50mg","slug":"albiglutide-50mg","indication":"Other","status":"marketed"},{"name":"Anticancer therapy 3","genericName":"Anticancer therapy 3","slug":"anticancer-therapy-3","indication":"Other","status":"phase_1"},{"name":"Anticholinergics","genericName":"Anticholinergics","slug":"anticholinergics","indication":"Other","status":"phase_2"},{"name":"Arnuity","genericName":"Arnuity","slug":"arnuity","indication":"Other","status":"marketed"},{"name":"Avamys aqueous nasal spray 110mcg","genericName":"Avamys aqueous nasal spray 110mcg","slug":"avamys-aqueous-nasal-spray-110mcg","indication":"Other","status":"marketed"},{"name":"Avandia","genericName":"Avandia","slug":"avandia","indication":"Other","status":"marketed"},{"name":"Avodart","genericName":"Avodart","slug":"avodart","indication":"Benign prostatic hyperplasia","status":"marketed"},{"name":"BOOSTRIX","genericName":"BOOSTRIX","slug":"boostrix","indication":"Other","status":"marketed"},{"name":"Benzoyl peroxide 3%","genericName":"Benzoyl peroxide 3%","slug":"benzoyl-peroxide-3","indication":"Other","status":"marketed"},{"name":"Beta-blockers including Carvedilol","genericName":"Beta-blockers including Carvedilol","slug":"beta-blockers-including-carvedilol","indication":"Other","status":"marketed"},{"name":"Boosted Protease Inhibitor","genericName":"Boosted Protease Inhibitor","slug":"boosted-protease-inhibitor","indication":"Other","status":"marketed"},{"name":"Boostrix-ex-US","genericName":"Boostrix-ex-US","slug":"boostrix-ex-us","indication":"Other","status":"phase_2"},{"name":"Brevicon","genericName":"Brevicon","slug":"brevicon","indication":"Other","status":"phase_1"},{"name":"Candesartan Cilexetil in formulation 1","genericName":"Candesartan Cilexetil in formulation 1","slug":"candesartan-cilexetil-in-formulation-1","indication":"Other","status":"phase_1"},{"name":"Candidate varicella vaccine","genericName":"Candidate varicella vaccine","slug":"candidate-varicella-vaccine","indication":"Prevention of varicella (chickenpox)","status":"phase_3"},{"name":"Capoten","genericName":"Capoten","slug":"capoten","indication":"Other","status":"discontinued"},{"name":"Capozide","genericName":"Capozide","slug":"capozide","indication":"Other","status":"discontinued"},{"name":"Cell-culture rabies vaccine","genericName":"Cell-culture rabies vaccine","slug":"cell-culture-rabies-vaccine","indication":"Rabies post-exposure prophylaxis","status":"phase_3"},{"name":"Cetirizine Dry Syrup","genericName":"Cetirizine Dry Syrup","slug":"cetirizine-dry-syrup","indication":"Allergic rhinitis","status":"phase_3"},{"name":"ChapStick Moisturizer, Classic Flavor","genericName":"ChapStick Moisturizer, Classic Flavor","slug":"chapstick-moisturizer-classic-flavor","indication":"Other","status":"phase_1"},{"name":"Chinese DT vaccine","genericName":"Chinese DT vaccine","slug":"chinese-dt-vaccine","indication":"Prevention of diphtheria and tetanus in pediatric and adult populations","status":"phase_3"},{"name":"Chlorhexidine Digluconate Mouthwash with Alcohol","genericName":"Chlorhexidine Digluconate Mouthwash with Alcohol","slug":"chlorhexidine-digluconate-mouthwash-with-alcohol","indication":"Other","status":"marketed"},{"name":"Chlorhexidine Digluconate Mouthwash without Alcohol","genericName":"Chlorhexidine Digluconate Mouthwash without Alcohol","slug":"chlorhexidine-digluconate-mouthwash-without-alcohol","indication":"Prevention and treatment of gingivitis","status":"marketed"},{"name":"Chloroquine, Tafenoquine","genericName":"Chloroquine, Tafenoquine","slug":"chloroquine-tafenoquine","indication":"Other","status":"phase_1"},{"name":"Colgate Cavity Protection","genericName":"Colgate Cavity Protection","slug":"colgate-cavity-protection","indication":"Cavity prevention and caries prophylaxis","status":"marketed"},{"name":"Combined diphtheria, tetanus, acellular pertussis vaccine","genericName":"Combined diphtheria, tetanus, acellular pertussis vaccine","slug":"combined-diphtheria-tetanus-acellular-pertussis-vaccine","indication":"Other","status":"marketed"},{"name":"Coumadin","genericName":"Coumadin","slug":"coumadin","indication":"Other","status":"marketed"},{"name":"Cumulative corticosteroid exposure","genericName":"Cumulative corticosteroid exposure","slug":"cumulative-corticosteroid-exposure","indication":"Other","status":"phase_2"},{"name":"Delayed combination therapy","genericName":"Delayed combination therapy","slug":"delayed-combination-therapy","indication":"Other","status":"phase_2"},{"name":"Detox-B adjuvant","genericName":"Detox-B adjuvant","slug":"detox-b-adjuvant","indication":"Vaccine adjuvant (indication under investigation in phase 3)","status":"phase_3"},{"name":"Disintegrating placebo tamsulosin tablet","genericName":"Disintegrating placebo tamsulosin tablet","slug":"disintegrating-placebo-tamsulosin-tablet","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms","status":"phase_3"},{"name":"Dose 1 BD","genericName":"Dose 1 BD","slug":"dose-1-bd","indication":"Other","status":"phase_2"},{"name":"Dutasteride plus tamsulosin","genericName":"Dutasteride plus tamsulosin","slug":"dutasteride-plus-tamsulosin","indication":"Other","status":"marketed"},{"name":"Dutasteride/Tamsulosin","genericName":"Dutasteride/Tamsulosin","slug":"dutasteride-tamsulosin","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms","status":"marketed"},{"name":"EXDENSUR","genericName":"DEPEMOKIMAB-ULAA","slug":"depemokimab-ulaa","indication":"Other","status":"marketed"},{"name":"Encepur Adults","genericName":"Encepur Adults","slug":"encepur-adults","indication":"Other","status":"marketed"},{"name":"Engerix™","genericName":"Engerix™","slug":"engerix","indication":"Other","status":"marketed"},{"name":"Exenatide 10microgram","genericName":"Exenatide 10microgram","slug":"exenatide-10microgram","indication":"Other","status":"marketed"},{"name":"Experimental Denture Adhesive","genericName":"Experimental Denture Adhesive","slug":"experimental-denture-adhesive","indication":"Denture retention and stability in edentulous patients","status":"phase_3"},{"name":"FF nasal spray","genericName":"FF nasal spray","slug":"ff-nasal-spray","indication":"Other","status":"marketed"},{"name":"FFNS","genericName":"FFNS","slug":"ffns","indication":"Other","status":"marketed"},{"name":"FLOVENT 250mcg","genericName":"FLOVENT 250mcg","slug":"flovent-250mcg","indication":"Other","status":"marketed"},{"name":"FLU HD vaccine","genericName":"FLU HD vaccine","slug":"flu-hd-vaccine","indication":"Prevention of influenza in adults aged 65 years and older","status":"phase_3"},{"name":"FLU-Q-PAN H7N9 Formulation 1","genericName":"FLU-Q-PAN H7N9 Formulation 1","slug":"flu-q-pan-h7n9-formulation-1","indication":"Other","status":"phase_2"},{"name":"FLU-Q-PAN H7N9 Formulation 2","genericName":"FLU-Q-PAN H7N9 Formulation 2","slug":"flu-q-pan-h7n9-formulation-2","indication":"Protection against H7N9 influenza","status":"phase_2"},{"name":"FLU-Q-PAN H7N9 Formulation 3","genericName":"FLU-Q-PAN H7N9 Formulation 3","slug":"flu-q-pan-h7n9-formulation-3","indication":"Other","status":"phase_2"},{"name":"FP 0.05%","genericName":"FP 0.05%","slug":"fp-0-05","indication":"Other","status":"phase_2"},{"name":"FP 500mcg","genericName":"FP 500mcg","slug":"fp-500mcg","indication":"Other","status":"marketed"},{"name":"Flu Pandemic mRNA_Dose level 2","genericName":"Flu Pandemic mRNA_Dose level 2","slug":"flu-pandemic-mrna-dose-level-2","indication":"Other","status":"phase_1"},{"name":"Flu Pandemic mRNA_Dose level 5","genericName":"Flu Pandemic mRNA_Dose level 5","slug":"flu-pandemic-mrna-dose-level-5","indication":"Other","status":"phase_1"},{"name":"FluLavalTM-VB","genericName":"FluLavalTM-VB","slug":"flulavaltm-vb","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"FluLavalTM-YB","genericName":"FluLavalTM-YB","slug":"flulavaltm-yb","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"FluLaval® Quadrivalent","genericName":"FluLaval® Quadrivalent","slug":"flulaval-quadrivalent","indication":"Seasonal influenza prevention in adults and children (6 months and older)","status":"phase_3"},{"name":"Fluarix TM","genericName":"Fluarix TM","slug":"fluarix-tm","indication":"Seasonal influenza prevention in adults and children ≥6 months of age","status":"phase_3"},{"name":"Fluarix Tetra Vaccine","genericName":"Fluarix Tetra Vaccine","slug":"fluarix-tetra-vaccine","indication":"Influenza prophylaxis in adults and children ≥6 months of age","status":"marketed"},{"name":"Fluarix and adjuvanted influenza vaccine","genericName":"Fluarix and adjuvanted influenza vaccine","slug":"fluarix-and-adjuvanted-influenza-vaccine","indication":"Prevention of influenza disease caused by influenza A and B viruses in people 6 months of age and older.","status":"phase_2"},{"name":"Fluarix vaccine","genericName":"Fluarix vaccine","slug":"fluarix-vaccine","indication":"Other","status":"marketed"},{"name":"Fluarix/Influsplit SSW 2012-2013","genericName":"Fluarix/Influsplit SSW 2012-2013","slug":"fluarix-influsplit-ssw-2012-2013","indication":"Seasonal influenza prevention in adults and children ≥6 months of age (2012-2013 season)","status":"phase_3"},{"name":"Fluarix™","genericName":"Fluarix™","slug":"fluarix","indication":"Other","status":"marketed"},{"name":"Fluarix™ YB","genericName":"Fluarix™ YB","slug":"fluarix-yb","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"Fluarix™/Influsplit SSW®","genericName":"Fluarix™/Influsplit SSW®","slug":"fluarix-influsplit-ssw","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":32,"colorKey":"cardiovascular","drugs":[{"name":"TIO","genericName":"TIO","slug":"tio","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"},{"name":"Exdensur","genericName":"DEPEMOKIMAB","slug":"depemokimab","indication":"severe asthma","status":"marketed"},{"name":"FF/VI","genericName":"FF/VI","slug":"ff-vi","indication":"Asthma maintenance treatment","status":"phase_3"},{"name":"FF/VI (200/25) mcg","genericName":"FF/VI (200/25) mcg","slug":"ff-vi-200-25-mcg","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"phase_3"},{"name":"FSC","genericName":"FSC","slug":"fsc","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"GW685698X","genericName":"GW685698X","slug":"gw685698x","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"},{"name":"ICS/LABA medication","genericName":"ICS/LABA medication","slug":"ics-laba-medication","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"Mepolizumab 250","genericName":"Mepolizumab 250","slug":"mepolizumab-250","indication":"Asthma","status":"phase_2"},{"name":"RELVAR/BREO","genericName":"RELVAR/BREO","slug":"relvar-breo","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"},{"name":"SB213503 lot 3","genericName":"SB213503 lot 3","slug":"sb213503-lot-3","indication":"Asthma (eosinophilic phenotype)","status":"phase_3"},{"name":"SFC","genericName":"SFC","slug":"sfc","indication":"Asthma maintenance treatment","status":"marketed"},{"name":"Salmeterol (DISKUS)","genericName":"Salmeterol (DISKUS)","slug":"salmeterol-diskus","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"tiotropium bromide inhalation powder HandiHaler","genericName":"tiotropium bromide inhalation powder HandiHaler","slug":"tiotropium-bromide-inhalation-powder-handihaler","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"},{"name":"Adjuvanted RSVPreF3 vaccine","genericName":"Adjuvanted RSVPreF3 vaccine","slug":"adjuvanted-rsvpref3-vaccine","indication":"Prevention of respiratory syncytial virus (RSV) disease in adults","status":"phase_2"},{"name":"Albuterol/salbutamol","genericName":"Albuterol/salbutamol","slug":"albuterol-salbutamol","indication":"Acute bronchospasm and reversible airway obstruction in asthma","status":"marketed"},{"name":"Albuterol/salbutamol MDI","genericName":"Albuterol/salbutamol MDI","slug":"albuterol-salbutamol-mdi","indication":"Acute bronchospasm and reversible airway obstruction in asthma","status":"marketed"},{"name":"Albuterol/salbutamol MDIs","genericName":"Albuterol/salbutamol MDIs","slug":"albuterol-salbutamol-mdis","indication":"Acute bronchospasm relief in asthma","status":"marketed"},{"name":"BRL29060A","genericName":"BRL29060A","slug":"brl29060a","indication":"Asthma","status":"phase_3"},{"name":"COPD rescue medications","genericName":"COPD rescue medications","slug":"copd-rescue-medications","indication":"Acute bronchospasm relief in chronic obstructive pulmonary disease (COPD)","status":"marketed"},{"name":"FF","genericName":"FF","slug":"ff","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"},{"name":"FF Inhalation Powder","genericName":"FF Inhalation Powder","slug":"ff-inhalation-powder","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"FF via ELLIPTA DPI","genericName":"FF via ELLIPTA DPI","slug":"ff-via-ellipta-dpi","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"FF/GW642444 Inhalation Powder","genericName":"FF/GW642444 Inhalation Powder","slug":"ff-gw642444-inhalation-powder","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"},{"name":"FF/UMEC/VI (100/31.25/25) mcg","genericName":"FF/UMEC/VI (100/31.25/25) mcg","slug":"ff-umec-vi-100-31-25-25-mcg","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"phase_3"},{"name":"FF/UMEC/VI (100/62.5/25) mcg","genericName":"FF/UMEC/VI (100/62.5/25) mcg","slug":"ff-umec-vi-100-62-5-25-mcg","indication":"Chronic obstructive pulmonary disease (COPD) maintenance therapy","status":"phase_3"},{"name":"FF/UMEC/VI (200/31.25/25) mcg","genericName":"FF/UMEC/VI (200/31.25/25) mcg","slug":"ff-umec-vi-200-31-25-25-mcg","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"phase_3"},{"name":"FF/UMEC/VI (200/62.5/25) mcg","genericName":"FF/UMEC/VI (200/62.5/25) mcg","slug":"ff-umec-vi-200-62-5-25-mcg","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"phase_3"},{"name":"FF/VI (100/25) mcg","genericName":"FF/VI (100/25) mcg","slug":"ff-vi-100-25-mcg","indication":"Asthma maintenance treatment","status":"phase_3"},{"name":"FF/VI 100/25 Inhalation Powder NDPI","genericName":"FF/VI 100/25 Inhalation Powder NDPI","slug":"ff-vi-100-25-inhalation-powder-ndpi","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"phase_3"},{"name":"FF/VI via ELLIPTA DPI","genericName":"FF/VI via ELLIPTA DPI","slug":"ff-vi-via-ellipta-dpi","indication":"Chronic obstructive pulmonary disease (COPD) maintenance therapy","status":"phase_3"},{"name":"FLIXOTIDE and SERETIDE","genericName":"FLIXOTIDE and SERETIDE","slug":"flixotide-and-seretide","indication":"Asthma maintenance therapy","status":"marketed"},{"name":"FLOVENT 500mcg","genericName":"FLOVENT 500mcg","slug":"flovent-500mcg","indication":"Maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":30,"colorKey":"respiratory","drugs":[{"name":"Cefadroxil tablets manufactured by GSK","genericName":"Cefadroxil tablets manufactured by GSK","slug":"cefadroxil-tablets-manufactured-by-gsk","indication":"Bacterial infections caused by susceptible organisms including skin and soft tissue infections","status":"marketed"},{"name":"Cefadroxil tablets manufactured by NP","genericName":"Cefadroxil tablets manufactured by NP","slug":"cefadroxil-tablets-manufactured-by-np","indication":"Urinary tract infections","status":"marketed"},{"name":"GSK Malaria vaccine 257049","genericName":"GSK Malaria vaccine 257049","slug":"gsk-malaria-vaccine-257049","indication":"Malaria prevention","status":"phase_2"},{"name":"Placebo matching gepotidacin","genericName":"Placebo matching gepotidacin","slug":"placebo-matching-gepotidacin","indication":"Uncomplicated urogenital gonorrhea","status":"phase_3"},{"name":"Pneumococcal (vaccine)","genericName":"Pneumococcal (vaccine)","slug":"pneumococcal-vaccine","indication":"Prevention of invasive pneumococcal disease (pneumonia, bacteremia, meningitis)","status":"marketed"},{"name":"Prevnar13","genericName":"Prevnar13","slug":"prevnar13","indication":"Prevention of invasive pneumococcal disease in infants and children (2 months to 5 years)","status":"marketed"},{"name":"SynflorixTM","genericName":"SynflorixTM","slug":"synflorixtm","indication":"Prevention of invasive pneumococcal disease in infants and children","status":"phase_3"},{"name":"Tritanrix-HepB","genericName":"Tritanrix-HepB","slug":"tritanrix-hepb","indication":"Protection against diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenzae type b in infants and children","status":"phase_3"},{"name":"Tritanrix-HepB/Meningitec conjugate vaccine","genericName":"Tritanrix-HepB/Meningitec conjugate vaccine","slug":"tritanrix-hepb-meningitec-conjugate-vaccine","indication":"Protection against diphtheria, tetanus, pertussis, hepatitis B, and meningococcal serogroups A, C, W, and Y in infants and young children","status":"phase_3"},{"name":"Wyeth-Lederle's Prevenar™","genericName":"Wyeth-Lederle's Prevenar™","slug":"wyeth-lederle-s-prevenar","indication":"Prevention of invasive disease caused by Streptococcus pneumoniae in infants and young children","status":"phase_3"},{"name":"ACT guided Routine Treatment","genericName":"ACT guided Routine Treatment","slug":"act-guided-routine-treatment","indication":"Malaria (uncomplicated and severe forms)","status":"marketed"},{"name":"Abacavir/Lamivudine","genericName":"Abacavir/Lamivudine","slug":"abacavir-lamivudine","indication":"HIV-1 infection (as part of combination antiretroviral therapy)","status":"marketed"},{"name":"Abacavir/lamivudine and efavirenz","genericName":"Abacavir/lamivudine and efavirenz","slug":"abacavir-lamivudine-and-efavirenz","indication":"HIV-1 infection in treatment-naïve and treatment-experienced patients","status":"marketed"},{"name":"Adefor dipivoxil","genericName":"Adefor dipivoxil","slug":"adefor-dipivoxil","indication":"Chronic hepatitis B infection","status":"marketed"},{"name":"Adefovir tablets","genericName":"Adefovir tablets","slug":"adefovir-tablets","indication":"Chronic hepatitis B","status":"phase_2"},{"name":"Amoxicillin and clavulanate","genericName":"Amoxicillin and clavulanate","slug":"amoxicillin-and-clavulanate","indication":"Lower Respiratory Tract Infections","status":"marketed"},{"name":"Artemether + Lumefantrine","genericName":"Artemether + Lumefantrine","slug":"artemether-lumefantrine","indication":"Uncomplicated malaria caused by Plasmodium falciparum","status":"marketed"},{"name":"Augmentin (ES)-600","genericName":"Augmentin (ES)-600","slug":"augmentin-es-600","indication":"Acute otitis media in pediatric patients","status":"marketed"},{"name":"Blujepa","genericName":"GEPOTIDACIN","slug":"gepotidacin","indication":"Uncomplicated urinary tract infections","status":"marketed"},{"name":"CLDM 1% gel","genericName":"CLDM 1% gel","slug":"cldm-1-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"CLDM 1% gel twice daily","genericName":"CLDM 1% gel twice daily","slug":"cldm-1-gel-twice-daily","indication":"Acne vulgaris (topical treatment)","status":"phase_3"},{"name":"CV0601 mRNA COVID-19 Vaccine","genericName":"CV0601 mRNA COVID-19 Vaccine","slug":"cv0601-mrna-covid-19-vaccine","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus","status":"phase_2"},{"name":"Candidate Plasmodium falciparum malaria vaccine","genericName":"Candidate Plasmodium falciparum malaria vaccine","slug":"candidate-plasmodium-falciparum-malaria-vaccine","indication":"Plasmodium falciparum malaria prevention in endemic populations","status":"phase_3"},{"name":"Combined Hepatitis A and B vaccine","genericName":"Combined Hepatitis A and B vaccine","slug":"combined-hepatitis-a-and-b-vaccine","indication":"Prevention of hepatitis A infection","status":"phase_3"},{"name":"Control vaccine with the adjuvant system.","genericName":"Control vaccine with the adjuvant system.","slug":"control-vaccine-with-the-adjuvant-system","indication":"Prevention of COVID-19","status":"phase_2"},{"name":"DTPw-HBV/Hib-MenAC conjugate vaccine","genericName":"DTPw-HBV/Hib-MenAC conjugate vaccine","slug":"dtpw-hbv-hib-menac-conjugate-vaccine","indication":"Prevention of diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, and Neisseria meningitidis serogroups A and C in infants and children","status":"phase_3"},{"name":"Engerix TM","genericName":"Engerix TM","slug":"engerix-tm","indication":"Prevention of hepatitis B infection in infants, children, and adults","status":"phase_3"},{"name":"Engerix-B vaccine","genericName":"Engerix-B vaccine","slug":"engerix-b-vaccine","indication":"Prevention of hepatitis B infection in infants, children, and adults","status":"marketed"},{"name":"Engerix-BTM","genericName":"Engerix-BTM","slug":"engerix-btm","indication":"Prevention of hepatitis B infection in infants, children, and adults","status":"phase_3"},{"name":"EngerixTM-B","genericName":"EngerixTM-B","slug":"engerixtm-b","indication":"Prevention of hepatitis B infection in infants, children, and adults","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":18,"colorKey":"infectious","drugs":[{"name":"CCI18781","genericName":"CCI18781","slug":"cci18781","indication":"Advanced solid tumors (in combination with checkpoint inhibitors)","status":"phase_3"},{"name":"CervarixTM","genericName":"CervarixTM","slug":"cervarixtm","indication":"Prevention of cervical cancer caused by HPV types 16 and 18","status":"phase_3"},{"name":"Delayed Maintenance treatment","genericName":"Delayed Maintenance treatment","slug":"delayed-maintenance-treatment","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_2"},{"name":"GSK580299, GSK Biological's HPV vaccine","genericName":"GSK580299, GSK Biological's HPV vaccine","slug":"gsk580299-gsk-biological-s-hpv-vaccine","indication":"Prevention of cervical cancer and precancerous lesions caused by HPV","status":"phase_3"},{"name":"MR-Vac","genericName":"MR-Vac","slug":"mr-vac","indication":"Ovarian cancer (in development)","status":"phase_3"},{"name":"RITUXIMAB + DHAP","genericName":"RITUXIMAB + DHAP","slug":"rituximab-dhap","indication":"Relapsed or refractory non-Hodgkin lymphoma","status":"phase_3"},{"name":"1278863A","genericName":"1278863A","slug":"1278863a","indication":"Chronic lymphocytic leukemia (CLL)","status":"phase_2"},{"name":"AFX3772","genericName":"AFX3772","slug":"afx3772","indication":"FGFR-altered solid tumors (Phase 2 development)","status":"phase_2"},{"name":"AltSonflex1-2-3","genericName":"AltSonflex1-2-3","slug":"altsonflex1-2-3","indication":"Metastatic basal cell carcinoma","status":"phase_2"},{"name":"Arzerra","genericName":"Arzerra","slug":"arzerra","indication":"Chronic lymphoid leukemia, disease","status":"marketed"},{"name":"Belantamab mafodotin frozen liquid","genericName":"Belantamab mafodotin frozen liquid","slug":"belantamab-mafodotin-frozen-liquid","indication":"Multiple myeloma","status":"phase_2"},{"name":"Belantamab mafodotin lyophilized powder","genericName":"Belantamab mafodotin lyophilized powder","slug":"belantamab-mafodotin-lyophilized-powder","indication":"Multiple myeloma","status":"phase_2"},{"name":"Cervarix TM","genericName":"Cervarix TM","slug":"cervarix-tm","indication":"Prevention of cervical cancer caused by HPV types 16 and 18","status":"phase_3"},{"name":"Cervarix vaccine","genericName":"Cervarix vaccine","slug":"cervarix-vaccine","indication":"Prevention of cervical cancer caused by HPV types 16 and 18","status":"phase_2"},{"name":"CervarixTM (GSK580299)","genericName":"CervarixTM (GSK580299)","slug":"cervarixtm-gsk580299","indication":"Prevention of cervical cancer caused by HPV types 16 and 18","status":"phase_3"},{"name":"Epoetin alfa vials","genericName":"Epoetin alfa vials","slug":"epoetin-alfa-vials","indication":"Anemia associated with chronic kidney disease","status":"phase_3"},{"name":"Epoetin beta pegol","genericName":"Epoetin beta pegol","slug":"epoetin-beta-pegol","indication":"Anemia in patients with chronic kidney disease","status":"phase_3"},{"name":"FEC75","genericName":"FEC75","slug":"fec75","indication":"Adjuvant treatment of node-positive breast cancer","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"immunology","drugs":[{"name":"ROP","genericName":"ROP","slug":"rop","indication":"Type 2 diabetes (marketed in some regions)","status":"marketed"},{"name":"rosiglitazone maleate/metformin hydrochloride","genericName":"rosiglitazone maleate/metformin hydrochloride","slug":"rosiglitazone-maleate-metformin-hydrochloride","indication":"Type 2 diabetes mellitus","status":"marketed"},{"name":"AAPA","genericName":"AAPA","slug":"aapa","indication":"Treatment of type 2 diabetes","status":"phase_3"},{"name":"GSK232802","genericName":"GSK232802","slug":"gsk232802","indication":"Type 2 diabetes","status":"phase_2"},{"name":"PAAA","genericName":"PAAA","slug":"paaa","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Albiglutide Lyophilized DCC Pen Injector","genericName":"Albiglutide Lyophilized DCC Pen Injector","slug":"albiglutide-lyophilized-dcc-pen-injector","indication":"Type 2 diabetes","status":"phase_1"},{"name":"Albiglutide liquid auto-injector","genericName":"Albiglutide liquid auto-injector","slug":"albiglutide-liquid-auto-injector","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"Albiglutide weekly injection","genericName":"Albiglutide weekly injection","slug":"albiglutide-weekly-injection","indication":"Type 2 diabetes","status":"phase_2"},{"name":"Antara (fenofibrate) + Lovaza","genericName":"Antara (fenofibrate) + Lovaza","slug":"antara-fenofibrate-lovaza","indication":"Hypertriglyceridemia (elevated triglycerides)","status":"marketed"},{"name":"Exenatide placebo (saline)","genericName":"Exenatide placebo (saline)","slug":"exenatide-placebo-saline","indication":"Control arm in clinical trials of exenatide for type 2 diabetes","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"rare","drugs":[{"name":"Losmapimod tablets","genericName":"Losmapimod tablets","slug":"losmapimod-tablets","indication":"Hypertension","status":"phase_2"},{"name":"ACE inhibitors","genericName":"ACE inhibitors","slug":"ace-inhibitors","indication":"Hypertension","status":"marketed"},{"name":"ARIXTRA infusion","genericName":"ARIXTRA infusion","slug":"arixtra-infusion","indication":"Prophylaxis of venous thromboembolism in patients undergoing hip fracture surgery, hip replacement surgery, or knee replacement surgery","status":"phase_3"},{"name":"Amlodipine 5 or 10 mg(oral)","genericName":"Amlodipine 5 or 10 mg(oral)","slug":"amlodipine-5-or-10-mg-oral","indication":"Hypertension","status":"marketed"},{"name":"CCB use","genericName":"CCB use","slug":"ccb-use","indication":"Hypertension","status":"phase_2"},{"name":"Carvedilol Phosphate modified release formulation","genericName":"Carvedilol Phosphate modified release formulation","slug":"carvedilol-phosphate-modified-release-formulation","indication":"Hypertension","status":"phase_3"},{"name":"Carvedilol extended release only","genericName":"Carvedilol extended release only","slug":"carvedilol-extended-release-only","indication":"Hypertension","status":"phase_2"},{"name":"Control - UFH","genericName":"Control - UFH","slug":"control-ufh","indication":"Acute venous thromboembolism (DVT/PE) treatment and prevention","status":"phase_3"},{"name":"Enoxaparine infusion","genericName":"Enoxaparine infusion","slug":"enoxaparine-infusion","indication":"Thromboembolism prophylaxis in surgical patients","status":"phase_3"},{"name":"FLOLAN injection with reformulated diluent","genericName":"FLOLAN injection with reformulated diluent","slug":"flolan-injection-with-reformulated-diluent","indication":"Pulmonary arterial hypertension (PAH)","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"metabolic","drugs":[{"name":"Nuceiva","genericName":"BOTULINUM TOXIN TYPE A","slug":"botulinum-toxin-type-a","indication":"Lower limb spasticity","status":"marketed"},{"name":"Ropinirole XL (formerly CR)","genericName":"Ropinirole XL (formerly CR)","slug":"ropinirole-xl-formerly-cr","indication":"Treatment of Parkinson's disease","status":"phase_3"},{"name":"ropinirole IR","genericName":"ropinirole IR","slug":"ropinirole-ir","indication":"Parkinson's disease","status":"phase_3"},{"name":"ACs","genericName":"ACs","slug":"acs","indication":"Chronic obstructive pulmonary disease (COPD)","status":"marketed"},{"name":"BW430C (lamotrigine)","genericName":"BW430C (lamotrigine)","slug":"bw430c-lamotrigine","indication":"Epilepsy (adjunctive therapy for partial seizures)","status":"phase_3"},{"name":"Botulinum toxin A (GSK1358820)","genericName":"Botulinum toxin A (GSK1358820)","slug":"botulinum-toxin-a-gsk1358820","indication":"Cervical dystonia","status":"phase_3"},{"name":"Ezogabine/Retigabine IR","genericName":"Ezogabine/Retigabine IR","slug":"ezogabine-retigabine-ir","indication":"Partial-onset seizures (adjunctive therapy in adults)","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"ophthalmology","drugs":[{"name":"SB-275833 ointment, 1%","genericName":"SB-275833 ointment, 1%","slug":"sb-275833-ointment-1","indication":"Inflammatory skin conditions (specific indication not publicly detailed in phase 3)","status":"phase_3"},{"name":"CCK (Kinevac)","genericName":"CCK (Kinevac)","slug":"cck-kinevac","indication":"Diagnostic agent for assessment of gallbladder function and biliary dyskinesia","status":"marketed"},{"name":"Clindamycin + BPO","genericName":"Clindamycin + BPO","slug":"clindamycin-bpo","indication":"Acne vulgaris (inflammatory and comedonal)","status":"marketed"},{"name":"Depemokimab (GSK3511294)","genericName":"Depemokimab (GSK3511294)","slug":"depemokimab-gsk3511294","indication":"Moderate-to-severe atopic dermatitis","status":"phase_3"},{"name":"Duac® fixed dose combination gel","genericName":"Duac® fixed dose combination gel","slug":"duac-fixed-dose-combination-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"Duac™Once Daily Gel","genericName":"Duac™Once Daily Gel","slug":"duaconce-daily-gel","indication":"Acne vulgaris","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"dermatology","drugs":[{"name":"rhEPO","genericName":"rhEPO","slug":"rhepo","indication":"Anemia associated with chronic kidney disease","status":"phase_3"},{"name":"Daprodustat (GSK1278863)","genericName":"Daprodustat (GSK1278863)","slug":"daprodustat-gsk1278863","indication":"Anemia of chronic kidney disease","status":"phase_3"},{"name":"Daprodustat large","genericName":"Daprodustat large","slug":"daprodustat-large","indication":"Anemia of chronic kidney disease in patients on dialysis","status":"phase_3"},{"name":"Daprodustat small","genericName":"Daprodustat small","slug":"daprodustat-small","indication":"Anemia of chronic kidney disease in patients not on dialysis","status":"phase_3"},{"name":"Daprodustat tablets","genericName":"Daprodustat tablets","slug":"daprodustat-tablets","indication":"Anemia in chronic kidney disease (CKD) patients on dialysis","status":"phase_3"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"pain","drugs":[{"name":"5ARI","genericName":"5ARI","slug":"5ari","indication":"Benign prostatic hyperplasia","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"hematology","drugs":[{"name":"Co-Codamol","genericName":"Co-Codamol","slug":"co-codamol","indication":"Pain relief","status":"phase_2"}]}],"pipeline":[{"name":"Benlysta","genericName":"Benlysta","slug":"benlysta","phase":"marketed","mechanism":"Tumor necrosis factor ligand superfamily member 13B","indications":["Systemic lupus erythematosus"],"catalyst":""},{"name":"ROP","genericName":"ROP","slug":"rop","phase":"marketed","mechanism":"ROP is a retinoid X receptor (RXR) agonist that modulates nuclear receptor signaling to regulate gene expression involved in metabolic and inflammatory pathways.","indications":["Type 2 diabetes (marketed in some regions)","Dyslipidemia"],"catalyst":""},{"name":"TIO","genericName":"TIO","slug":"tio","phase":"marketed","mechanism":"Tiotropium is a long-acting anticholinergic bronchodilator that blocks muscarinic M3 receptors in airway smooth muscle to produce sustained airway relaxation.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment (in combination with inhaled corticosteroids)"],"catalyst":""},{"name":"rosiglitazone maleate/metformin hydrochloride","genericName":"rosiglitazone maleate/metformin hydrochloride","slug":"rosiglitazone-maleate-metformin-hydrochloride","phase":"marketed","mechanism":"This combination drug improves blood sugar control by increasing insulin sensitivity through a thiazolidinedione and reducing hepatic glucose production through a biguanide.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"AAPA","genericName":"AAPA","slug":"aapa","phase":"phase_3","mechanism":"AAPA is a small molecule that targets the SGLT2 receptor.","indications":["Treatment of type 2 diabetes"],"catalyst":""},{"name":"ADOAIR250","genericName":"ADOAIR250","slug":"adoair250","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AS03B","genericName":"AS03B","slug":"as03b","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ASP3772","genericName":"ASP3772","slug":"asp3772","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ActHIB®","genericName":"ActHIB®","slug":"acthib","phase":"marketed","mechanism":"ActHIB is a conjugate vaccine that stimulates the immune system to produce antibodies against Haemophilus influenzae type b (Hib) bacteria.","indications":["Prevention of invasive disease caused by Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"Additional challenge dose","genericName":"Additional challenge dose","slug":"additional-challenge-dose","phase":"marketed","mechanism":"Additional challenge dose is used to stimulate the immune system to produce antibodies against a specific antigen.","indications":["Influenza"],"catalyst":""},{"name":"Amine Fluoride Toothpaste","genericName":"Amine Fluoride Toothpaste","slug":"amine-fluoride-toothpaste","phase":"phase_3","mechanism":"Amine fluoride toothpaste delivers fluoride ions to tooth enamel to strengthen it and prevent dental caries through remineralization.","indications":["Prevention of dental caries (cavities)","Remineralization of early enamel lesions","Fluoride supplementation for caries-prone patients"],"catalyst":""},{"name":"Anticancer therapy 4","genericName":"Anticancer therapy 4","slug":"anticancer-therapy-4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Arepanrix®","genericName":"Arepanrix®","slug":"arepanrix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Boostrix Polio™ 711866","genericName":"Boostrix Polio™ 711866","slug":"boostrix-polio-711866","phase":"phase_3","mechanism":"Boostrix Polio is a combined vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","indications":["Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"],"catalyst":""},{"name":"Boostrix ® Polio","genericName":"Boostrix ® Polio","slug":"boostrix-polio","phase":"marketed","mechanism":"Boostrix Polio is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","indications":["Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"],"catalyst":""},{"name":"BoostrixTM Polio","genericName":"BoostrixTM Polio","slug":"boostrixtm-polio","phase":"marketed","mechanism":"Boostrix Polio is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","indications":["Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"],"catalyst":""},{"name":"CCI18781","genericName":"CCI18781","slug":"cci18781","phase":"phase_3","mechanism":"CCI18781 is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) that reduces macrophage proliferation and activation in the tumor microenvironment.","indications":["Advanced solid tumors (in combination with checkpoint inhibitors)"],"catalyst":""},{"name":"Cefadroxil tablets manufactured by GSK","genericName":"Cefadroxil tablets manufactured by GSK","slug":"cefadroxil-tablets-manufactured-by-gsk","phase":"marketed","mechanism":"Cefadroxil inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands.","indications":["Bacterial infections caused by susceptible organisms including skin and soft tissue infections","Urinary tract infections","Respiratory tract infections","Streptococcal pharyngitis"],"catalyst":""},{"name":"Cefadroxil tablets manufactured by NP","genericName":"Cefadroxil tablets manufactured by NP","slug":"cefadroxil-tablets-manufactured-by-np","phase":"marketed","mechanism":"Cefadroxil is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands.","indications":["Urinary tract infections","Skin and soft tissue infections","Respiratory tract infections","Streptococcal pharyngitis"],"catalyst":""},{"name":"Cervarix","genericName":"Cervarix","slug":"cervarix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"CervarixTM","genericName":"CervarixTM","slug":"cervarixtm","phase":"phase_3","mechanism":"Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.","indications":["Prevention of cervical cancer caused by HPV types 16 and 18","Prevention of cervical intraepithelial neoplasia (CIN) grades 1, 2, and 3 caused by HPV types 16 and 18"],"catalyst":""},{"name":"Cherry lamotrigine ODT","genericName":"Cherry lamotrigine ODT","slug":"cherry-lamotrigine-odt","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Delayed Maintenance treatment","genericName":"Delayed Maintenance treatment","slug":"delayed-maintenance-treatment","phase":"phase_2","mechanism":"This drug targets the PD-1 receptor to suppress cancer cell growth.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"Exdensur","genericName":"DEPEMOKIMAB","slug":"depemokimab","phase":"marketed","mechanism":"Exdensur works by binding to histamine, preventing it from interacting with its receptors and reducing inflammation and airway constriction.","indications":["severe asthma","acute bronchospasm","status asthmaticus"],"catalyst":""},{"name":"FF ELLIPTA DPI","genericName":"FF ELLIPTA DPI","slug":"ff-ellipta-dpi","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FF/VI","genericName":"FF/VI","slug":"ff-vi","phase":"phase_3","mechanism":"FF/VI is a combination inhaled corticosteroid (fluticasone furoate) and long-acting beta-2 agonist (vilanterol) that reduces airway inflammation and improves bronchodilation in respiratory disease.","indications":["Asthma maintenance treatment","Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/VI (200/25) mcg","genericName":"FF/VI (200/25) mcg","slug":"ff-vi-200-25-mcg","phase":"phase_3","mechanism":"FF/VI is a combination inhaled corticosteroid (fluticasone furoate) and long-acting beta-2 agonist (vilanterol) that reduces airway inflammation and improves bronchodilation in obstructive airway diseases.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment"],"catalyst":""},{"name":"FLU-QIV","genericName":"FLU-QIV","slug":"flu-qiv","phase":"phase_3","mechanism":"FLU-QIV is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"FP","genericName":"FP","slug":"fp","phase":"marketed","mechanism":"FP is a fluorinated propellant and surfactant used as a metered-dose inhaler (MDI) propellant in respiratory drug formulations.","indications":[],"catalyst":""},{"name":"FP 250mcg","genericName":"FP 250mcg","slug":"fp-250mcg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FPNS","genericName":"FPNS","slug":"fpns","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FSC","genericName":"FSC","slug":"fsc","phase":"phase_3","mechanism":"FSC is a combination therapy that works through dual mechanisms to treat respiratory and inflammatory conditions.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Firategrast modified release tablet","genericName":"Firategrast modified release tablet","slug":"firategrast-modified-release-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fluarix-AS25","genericName":"Fluarix-AS25","slug":"fluarix-as25","phase":"phase_2","mechanism":"Fluarix-AS25 is an inactivated influenza vaccine.","indications":["Protection against influenza disease caused by the AS25 strain of the influenza virus"],"catalyst":""},{"name":"FluarixTM","genericName":"FluarixTM","slug":"fluarixtm","phase":"marketed","mechanism":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children ≥6 months of age"],"catalyst":""},{"name":"Fluarix™ VB","genericName":"Fluarix™ VB","slug":"fluarix-vb","phase":"phase_3","mechanism":"Fluarix VB is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"GR205171","genericName":"GR205171","slug":"gr205171","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GS856553","genericName":"GS856553","slug":"gs856553","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK Biologicals' DTPa-IPV/Hib vaccine","genericName":"GSK Biologicals' DTPa-IPV/Hib vaccine","slug":"gsk-biologicals-dtpa-ipv-hib-vaccine","phase":"phase_3","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"GSK Malaria vaccine 257049","genericName":"GSK Malaria vaccine 257049","slug":"gsk-malaria-vaccine-257049","phase":"phase_2","mechanism":"Induces immune response against Plasmodium falciparum","indications":["Malaria prevention"],"catalyst":""},{"name":"GSK investigational vaccine GSK1557482A","genericName":"GSK investigational vaccine GSK1557482A","slug":"gsk-investigational-vaccine-gsk1557482a","phase":"phase_3","mechanism":"GSK1557482A is an investigational therapeutic vaccine designed to stimulate immune responses against specific tumor-associated antigens or pathogens.","indications":["Investigational indication under phase 3 evaluation (specific indication not publicly confirmed)"],"catalyst":""},{"name":"GSK1325756","genericName":"GSK1325756","slug":"gsk1325756","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK1362885","genericName":"GSK1362885","slug":"gsk1362885","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK1399686","genericName":"GSK1399686","slug":"gsk1399686","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK232802","genericName":"GSK232802","slug":"gsk232802","phase":"phase_2","mechanism":"GSK232802 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"GSK2890457","genericName":"GSK2890457","slug":"gsk2890457","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK3036656","genericName":"GSK3036656","slug":"gsk3036656","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK3389404","genericName":"GSK3389404","slug":"gsk3389404","phase":"phase_2","mechanism":"GSK3389404 is a selective inhibitor of TYK2 (tyrosine kinase 2) that suppresses JAK-STAT signaling in immune cells to reduce inflammatory responses.","indications":["Psoriasis","Inflammatory bowel disease"],"catalyst":""},{"name":"GSK364735","genericName":"GSK364735","slug":"gsk364735","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GSK580299, GSK Biological's HPV vaccine","genericName":"GSK580299, GSK Biological's HPV vaccine","slug":"gsk580299-gsk-biological-s-hpv-vaccine","phase":"phase_3","mechanism":"GSK580299 is an HPV vaccine that stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types associated with cervical cancer and other HPV-related malignancies.","indications":["Prevention of cervical cancer and precancerous lesions caused by HPV","Prevention of other HPV-related cancers (anal, oropharyngeal, vulvar, vaginal)"],"catalyst":""},{"name":"GW677954","genericName":"GW677954","slug":"gw677954","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GW685698","genericName":"GW685698","slug":"gw685698","phase":"phase_3","mechanism":"GW685698 is a selective antagonist of the P2X7 receptor, an ATP-gated ion channel involved in inflammatory and immune responses.","indications":["Rheumatoid arthritis","Inflammatory bowel disease"],"catalyst":""},{"name":"GW685698X","genericName":"GW685698X","slug":"gw685698x","phase":"phase_3","mechanism":"GW685698X is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma"],"catalyst":""},{"name":"GW810781","genericName":"GW810781","slug":"gw810781","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GW842166","genericName":"GW842166","slug":"gw842166","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GW856553","genericName":"GW856553","slug":"gw856553","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HAVRIX","genericName":"HAVRIX","slug":"havrix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ICS/LABA medication","genericName":"ICS/LABA medication","slug":"ics-laba-medication","phase":"marketed","mechanism":"ICS/LABA combines an inhaled corticosteroid to reduce airway inflammation with a long-acting beta-2 agonist to relax airway smooth muscle and improve bronchodilation.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Infanrix Hib™","genericName":"Infanrix Hib™","slug":"infanrix-hib","phase":"phase_3","mechanism":"Infanrix Hib is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b (Hib) bacteria.","indications":["Primary immunization against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"Infanrix IPV","genericName":"Infanrix IPV","slug":"infanrix-ipv","phase":"marketed","mechanism":"Infanrix IPV is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and inactivated poliovirus.","indications":["Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in infants and children"],"catalyst":""},{"name":"Infanrix TM","genericName":"Infanrix TM","slug":"infanrix-tm","phase":"marketed","mechanism":"Infanrix is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.","indications":["Prevention of diphtheria, tetanus, and pertussis in infants and children (primary series and boosters)"],"catalyst":""},{"name":"Infanrix® Penta","genericName":"Infanrix® Penta","slug":"infanrix-penta","phase":"marketed","mechanism":"Infanrix Penta is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"Investigational varicella vaccine_Lot 2","genericName":"Investigational varicella vaccine_Lot 2","slug":"investigational-varicella-vaccine-lot-2","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to recognize and prevent varicella-zoster virus infection by inducing protective antibodies and cell-mediated immunity.","indications":["Prevention of varicella (chickenpox) in pediatric and adult populations"],"catalyst":""},{"name":"Losmapimod tablets","genericName":"Losmapimod tablets","slug":"losmapimod-tablets","phase":"phase_2","mechanism":"Rho kinase inhibitor","indications":["Hypertension"],"catalyst":""},{"name":"MR-Vac","genericName":"MR-Vac","slug":"mr-vac","phase":"phase_3","mechanism":"MR-Vac is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.","indications":["Ovarian cancer (in development)","Other solid tumors (investigational)"],"catalyst":""},{"name":"Marketed varicella vaccine_Lot 1","genericName":"Marketed varicella vaccine_Lot 1","slug":"marketed-varicella-vaccine-lot-1","phase":"phase_3","mechanism":"The varicella vaccine stimulates the immune system to produce antibodies and cellular immunity against the varicella-zoster virus, preventing chickenpox infection.","indications":["Prevention of varicella (chickenpox) in children and adults","Prevention of herpes zoster (shingles) in immunocompetent individuals"],"catalyst":""},{"name":"Mencevax™ ACW","genericName":"Mencevax™ ACW","slug":"mencevax-acw","phase":"phase_3","mechanism":"Mencevax ACW is a meningococcal polysaccharide conjugate vaccine that stimulates immune response against Neisseria meningitidis serogroups A, C, W, and Y.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y"],"catalyst":""},{"name":"Menitorix","genericName":"Menitorix","slug":"menitorix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"MenitorixTM","genericName":"MenitorixTM","slug":"menitorixtm","phase":"phase_3","mechanism":"Meningococcal conjugate vaccine that stimulates immune response against Neisseria meningitidis serogroups A, C, W, and Y.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in infants, children, adolescents, and adults"],"catalyst":""},{"name":"Mepolizumab 250","genericName":"Mepolizumab 250","slug":"mepolizumab-250","phase":"phase_2","mechanism":"Interleukin-5 antagonist","indications":["Asthma","Eosinophilic granulomatosis with polyangiitis (EGPA)"],"catalyst":""},{"name":"Merck and Company's Varivax","genericName":"Merck and Company's Varivax","slug":"merck-and-company-s-varivax","phase":"phase_3","mechanism":"Varivax is a live attenuated varicella-zoster virus vaccine that stimulates immune response to prevent chickenpox infection.","indications":["Prevention of varicella (chickenpox) in children and adults"],"catalyst":""},{"name":"Nicotine (4 mg)","genericName":"Nicotine (4 mg)","slug":"nicotine-4-mg","phase":"marketed","mechanism":"Nicotine binds to nicotinic acetylcholine receptors in the brain and peripheral nervous system, providing nicotine replacement to reduce cravings and withdrawal symptoms during smoking cessation.","indications":["Smoking cessation aid"],"catalyst":""},{"name":"Nicotine Lozenges","genericName":"Nicotine Lozenges","slug":"nicotine-lozenges","phase":"phase_3","mechanism":"Nicotine lozenges work by releasing nicotine into the bloodstream to help manage withdrawal symptoms and cravings associated with smoking cessation.","indications":["Smoking cessation"],"catalyst":""},{"name":"Nuceiva","genericName":"BOTULINUM TOXIN TYPE A","slug":"botulinum-toxin-type-a","phase":"marketed","mechanism":"Nuceiva works by blocking the release of acetylcholine, a neurotransmitter that transmits signals from nerve cells to muscles, thereby reducing muscle spasms and contractions.","indications":["Lower limb spasticity","Neurogenic bladder","Overactive bladder","Rhytidectomy of glabellar frown lines","Upper limb spasticity"],"catalyst":""},{"name":"PAAA","genericName":"PAAA","slug":"paaa","phase":"phase_3","mechanism":"PAAA is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Paracetamol formulation 4","genericName":"Paracetamol formulation 4","slug":"paracetamol-formulation-4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paracetamol medium dissolution suspension","genericName":"Paracetamol medium dissolution suspension","slug":"paracetamol-medium-dissolution-suspension","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Part A","genericName":"Part A","slug":"part-a","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Part B","genericName":"Part B","slug":"part-b","phase":"marketed","mechanism":"Part B refers to Medicare Part B, which is a government insurance program, not a pharmaceutical drug.","indications":[],"catalyst":""},{"name":"Placebo matching gepotidacin","genericName":"Placebo matching gepotidacin","slug":"placebo-matching-gepotidacin","phase":"phase_3","mechanism":"Gepotidacin is a novel bacterial topoisomerase inhibitor that prevents bacterial DNA replication and transcription by targeting DNA gyrase and topoisomerase IV.","indications":["Uncomplicated urogenital gonorrhea","Acute bacterial skin and skin structure infections"],"catalyst":""},{"name":"Pneumococcal (vaccine)","genericName":"Pneumococcal (vaccine)","slug":"pneumococcal-vaccine","phase":"marketed","mechanism":"A pneumococcal vaccine stimulates the immune system to produce antibodies and cellular immunity against Streptococcus pneumoniae bacteria.","indications":["Prevention of invasive pneumococcal disease (pneumonia, bacteremia, meningitis)","Prevention of pneumococcal otitis media and sinusitis"],"catalyst":""},{"name":"Polio Sabin","genericName":"Polio Sabin","slug":"polio-sabin","phase":"phase_3","mechanism":"The Polio Sabin vaccine works by introducing a weakened form of the poliovirus to stimulate an immune response.","indications":["Polio prevention"],"catalyst":""},{"name":"Poliorix TM","genericName":"Poliorix TM","slug":"poliorix-tm","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Prevenar 13","genericName":"Prevenar 13","slug":"prevenar-13","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Prevnar13","genericName":"Prevnar13","slug":"prevnar13","phase":"marketed","mechanism":"Prevnar 13 is a pneumococcal conjugate vaccine that stimulates the immune system to produce antibodies against 13 serotypes of Streptococcus pneumoniae.","indications":["Prevention of invasive pneumococcal disease in infants and children (2 months to 5 years)","Prevention of invasive pneumococcal disease in adults aged 50 years and older","Prevention of pneumococcal otitis media and pneumonia in pediatric populations"],"catalyst":""},{"name":"Priorix","genericName":"Priorix","slug":"priorix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"PriorixTetra™","genericName":"PriorixTetra™","slug":"priorixtetra","phase":"phase_3","mechanism":"PriorixTetra is a live attenuated vaccine that stimulates the body's immune system to produce antibodies against measles, mumps, rubella, and varicella.","indications":["Measles, mumps, rubella, and varicella prevention in individuals 9 months of age and older"],"catalyst":""},{"name":"RELVAR/BREO","genericName":"RELVAR/BREO","slug":"relvar-breo","phase":"marketed","mechanism":"RELVAR/BREO is a combination inhaler containing fluticasone furoate (an inhaled corticosteroid) and vilanterol (a long-acting beta-2 agonist) that reduces airway inflammation and improves bronchodilation in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment (in some markets)"],"catalyst":""},{"name":"RITUXIMAB + DHAP","genericName":"RITUXIMAB + DHAP","slug":"rituximab-dhap","phase":"phase_3","mechanism":"Rituximab is a monoclonal antibody that targets and depletes CD20-positive B cells, while DHAP is a chemotherapy regimen that includes the drugs dexamethasone, high-dose cytarabine, and cisplatin.","indications":["Relapsed or refractory non-Hodgkin lymphoma","Multiple myeloma"],"catalyst":""},{"name":"RSV F subunit 45 μg MF59 adjuvant","genericName":"RSV F subunit 45 μg MF59 adjuvant","slug":"rsv-f-subunit-45-g-mf59-adjuvant","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"RSV F subunit 45 μg No adjuvant","genericName":"RSV F subunit 45 μg No adjuvant","slug":"rsv-f-subunit-45-g-no-adjuvant","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"RSVPreF3 OA vaccine","genericName":"RSVPreF3 OA vaccine","slug":"rsvpref3-oa-vaccine","phase":"phase_3","mechanism":"RSVPreF3 OA is a recombinant protein vaccine that presents a stabilized prefusion form of the respiratory syncytial virus (RSV) F glycoprotein to elicit protective immune responses against RSV infection.","indications":["Prevention of respiratory syncytial virus (RSV) disease in older adults (≥60 years)","Prevention of RSV disease in infants via maternal immunization (under investigation)"],"catalyst":""},{"name":"Rabipur","genericName":"Rabipur","slug":"rabipur","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"RepevaxTM","genericName":"RepevaxTM","slug":"repevaxtm","phase":"phase_3","mechanism":"Repevax is a booster vaccine that provides protection against diphtheria, tetanus, pertussis, and poliomyelitis through immunization with inactivated antigens.","indications":["Booster vaccination against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"],"catalyst":""},{"name":"Ropinirole XL (formerly CR)","genericName":"Ropinirole XL (formerly CR)","slug":"ropinirole-xl-formerly-cr","phase":"phase_3","mechanism":"Ropinirole XL is a dopamine agonist that works by stimulating dopamine receptors in the brain.","indications":["Treatment of Parkinson's disease","Treatment of restless legs syndrome"],"catalyst":""},{"name":"Rotarix TM","genericName":"Rotarix TM","slug":"rotarix-tm","phase":"marketed","mechanism":"Rotarix is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.","indications":["Prevention of rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"Routine Treatment","genericName":"Routine Treatment","slug":"routine-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SB-275833 ointment, 1%","genericName":"SB-275833 ointment, 1%","slug":"sb-275833-ointment-1","phase":"phase_3","mechanism":"SB-275833 is a topical corticosteroid that reduces inflammation and immune response in skin conditions.","indications":["Inflammatory skin conditions (specific indication not publicly detailed in phase 3)"],"catalyst":""},{"name":"SB-659032","genericName":"SB-659032","slug":"sb-659032","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SB213503 lot 3","genericName":"SB213503 lot 3","slug":"sb213503-lot-3","phase":"phase_3","mechanism":"SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases.","indications":["Asthma (eosinophilic phenotype)","Allergic airway inflammation"],"catalyst":""},{"name":"SFC","genericName":"SFC","slug":"sfc","phase":"marketed","mechanism":"SFC is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.","indications":["Asthma maintenance treatment","Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"Salmeterol (DISKUS)","genericName":"Salmeterol (DISKUS)","slug":"salmeterol-diskus","phase":"marketed","mechanism":"Salmeterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Salmeterol 50 mcg via DISKUS","genericName":"Salmeterol 50 mcg via DISKUS","slug":"salmeterol-50-mcg-via-diskus","phase":"marketed","mechanism":"Salmeterol is a long-acting beta2-adrenergic agonist that relaxes bronchial smooth muscle to improve airflow.","indications":[],"catalyst":""},{"name":"Sodium Fluoride (NaF)","genericName":"Sodium Fluoride (NaF)","slug":"sodium-fluoride-naf","phase":"phase_3","mechanism":"Sodium fluoride strengthens tooth enamel and bone by incorporating fluoride ions into the mineral matrix, increasing resistance to demineralization and promoting remineralization.","indications":["Osteoporosis treatment and prevention","Dental caries prevention","Fluorosis management in endemic regions"],"catalyst":""},{"name":"Squarekids","genericName":"Squarekids","slug":"squarekids","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Standard therapy","genericName":"Standard therapy","slug":"standard-therapy","phase":"marketed","mechanism":"Standard therapy refers to the established, evidence-based treatment regimen for a given disease, typically comprising conventional pharmacological and/or non-pharmacological interventions.","indications":[],"catalyst":""},{"name":"Synflorix","genericName":"Synflorix","slug":"synflorix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"SynflorixTM","genericName":"SynflorixTM","slug":"synflorixtm","phase":"phase_3","mechanism":"Synflorix is a pneumococcal conjugate vaccine that stimulates immune responses against multiple serotypes of Streptococcus pneumoniae.","indications":["Prevention of invasive pneumococcal disease in infants and children","Prevention of pneumococcal pneumonia in pediatric populations"],"catalyst":""},{"name":"Test 2 Montelukast","genericName":"Test 2 Montelukast","slug":"test-2-montelukast","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tritanrix-HepB","genericName":"Tritanrix-HepB","slug":"tritanrix-hepb","phase":"phase_3","mechanism":"Tritanrix-HepB is a vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenzae type b.","indications":["Protection against diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"Tritanrix-HepB/Meningitec conjugate vaccine","genericName":"Tritanrix-HepB/Meningitec conjugate vaccine","slug":"tritanrix-hepb-meningitec-conjugate-vaccine","phase":"phase_3","mechanism":"Tritanrix-HepB/Meningitec conjugate vaccine works by stimulating the body's immune system to produce antibodies against diphtheria, tetanus, pertussis, hepatitis B, and meningococcal serogroups A, C, W, and Y.","indications":["Protection against diphtheria, tetanus, pertussis, hepatitis B, and meningococcal serogroups A, C, W, and Y in infants and young children"],"catalyst":""},{"name":"VI","genericName":"VI","slug":"vi","phase":"marketed","mechanism":"VI is a varicella zoster virus vaccine that stimulates immune response to prevent herpes zoster (shingles) infection.","indications":["Prevention of herpes zoster (shingles) in adults aged 50 years and older","Prevention of herpes zoster in immunocompromised adults aged 18 years and older"],"catalyst":""},{"name":"Varivax","genericName":"Varivax","slug":"varivax","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vaxneuvance","genericName":"Vaxneuvance","slug":"vaxneuvance","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Wyeth-Lederle's Prevenar™","genericName":"Wyeth-Lederle's Prevenar™","slug":"wyeth-lederle-s-prevenar","phase":"phase_3","mechanism":"Prevenar is a conjugate vaccine that stimulates the body to produce antibodies against Streptococcus pneumoniae.","indications":["Prevention of invasive disease caused by Streptococcus pneumoniae in infants and young children"],"catalyst":""},{"name":"rhEPO","genericName":"rhEPO","slug":"rhepo","phase":"phase_3","mechanism":"rhEPO stimulates erythropoiesis by binding to the erythropoietin receptor.","indications":["Anemia associated with chronic kidney disease","Anemia associated with chemotherapy"],"catalyst":""},{"name":"ropinirole IR","genericName":"ropinirole IR","slug":"ropinirole-ir","phase":"phase_3","mechanism":"Ropinirole IR works by activating dopamine receptors in the brain, increasing dopamine levels and helping to alleviate symptoms of Parkinson's disease.","indications":["Parkinson's disease","Restless legs syndrome"],"catalyst":""},{"name":"ropinirole monotherapy","genericName":"ropinirole monotherapy","slug":"ropinirole-monotherapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"rosiglitazone-metformin fixed dose combination","genericName":"rosiglitazone-metformin fixed dose combination","slug":"rosiglitazone-metformin-fixed-dose-combination","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"tiotropium bromide inhalation powder HandiHaler","genericName":"tiotropium bromide inhalation powder HandiHaler","slug":"tiotropium-bromide-inhalation-powder-handihaler","phase":"marketed","mechanism":"Tiotropium is a long-acting anticholinergic (antimuscarinic) agent that blocks muscarinic M3 receptors on airway smooth muscle to produce sustained bronchodilation.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment"],"catalyst":""},{"name":"1278863A","genericName":"1278863A","slug":"1278863a","phase":"phase_2","mechanism":"This drug is a small molecule that targets the PI3K delta subunit.","indications":["Chronic lymphocytic leukemia (CLL)","Sjögren's syndrome"],"catalyst":""},{"name":"14C-SB649868","genericName":"14C-SB649868","slug":"14c-sb649868","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"3% Benzoyl Peroxide","genericName":"3% Benzoyl Peroxide","slug":"3-benzoyl-peroxide","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"3% Menthol","genericName":"3% Menthol","slug":"3-menthol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"5% Potassium nitrate","genericName":"5% Potassium nitrate","slug":"5-potassium-nitrate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"5ARI","genericName":"5ARI","slug":"5ari","phase":"phase_2","mechanism":"5-alpha-reductase inhibitor","indications":["Benign prostatic hyperplasia","Androgenetic alopecia"],"catalyst":""},{"name":"89Zr-GSK2849330","genericName":"89Zr-GSK2849330","slug":"89zr-gsk2849330","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"89Zr-GSK3128349 1 mg","genericName":"89Zr-GSK3128349 1 mg","slug":"89zr-gsk3128349-1-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AAAA","genericName":"AAAA","slug":"aaaa","phase":"phase_3","mechanism":"AAAA is a small molecule that targets the molecular target.","indications":["Unknown"],"catalyst":""},{"name":"AB","genericName":"AB","slug":"ab","phase":"marketed","mechanism":"AB is a monoclonal antibody that binds to and inhibits a specific molecular target to modulate immune or disease-related pathways.","indications":[],"catalyst":""},{"name":"ACE inhibitors","genericName":"ACE inhibitors","slug":"ace-inhibitors","phase":"marketed","mechanism":"ACE inhibitors block the angiotensin-converting enzyme, preventing the conversion of angiotensin I to angiotensin II and thereby reducing vasoconstriction and aldosterone release.","indications":["Hypertension","Heart failure with reduced ejection fraction","Post-myocardial infarction","Diabetic nephropathy","Chronic kidney disease"],"catalyst":""},{"name":"ACT guided Routine Treatment","genericName":"ACT guided Routine Treatment","slug":"act-guided-routine-treatment","phase":"marketed","mechanism":"ACT guided Routine Treatment is a clinical management strategy that uses Artemisinin-based Combination Therapy (ACT) with routine diagnostic testing to optimize malaria treatment outcomes.","indications":["Malaria (uncomplicated and severe forms)"],"catalyst":""},{"name":"ACs","genericName":"ACs","slug":"acs","phase":"marketed","mechanism":"ACs are anticholinergic agents that block acetylcholine receptors to reduce parasympathetic nervous system activity.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma","Gastrointestinal disorders (antispasmodic use)","Parkinson's disease (tremor management)"],"catalyst":""},{"name":"ADA 0.1% gel","genericName":"ADA 0.1% gel","slug":"ada-0-1-gel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AFX3772","genericName":"AFX3772","slug":"afx3772","phase":"phase_2","mechanism":"AFX3772 is a selective inhibitor of fibroblast growth factor receptor (FGFR) signaling that blocks aberrant growth signals in cells dependent on FGFR activation.","indications":["FGFR-altered solid tumors (Phase 2 development)"],"catalyst":""},{"name":"ARIXTRA infusion","genericName":"ARIXTRA infusion","slug":"arixtra-infusion","phase":"phase_3","mechanism":"ARIXTRA (fondaparinux) selectively inhibits Factor Xa in the coagulation cascade, preventing thrombin generation and blood clot formation.","indications":["Prophylaxis of venous thromboembolism in patients undergoing hip fracture surgery, hip replacement surgery, or knee replacement surgery","Treatment of acute deep vein thrombosis","Treatment of acute pulmonary embolism","Prophylaxis of thromboembolism in patients with acute coronary syndrome"],"catalyst":""},{"name":"AS03A","genericName":"AS03A","slug":"as03a","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Abacavir/Lamivudine","genericName":"Abacavir/Lamivudine","slug":"abacavir-lamivudine","phase":"marketed","mechanism":"Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs) that block HIV reverse transcriptase, preventing viral replication by inhibiting conversion of viral RNA to DNA.","indications":["HIV-1 infection (as part of combination antiretroviral therapy)"],"catalyst":""},{"name":"Abacavir/lamivudine and efavirenz","genericName":"Abacavir/lamivudine and efavirenz","slug":"abacavir-lamivudine-and-efavirenz","phase":"marketed","mechanism":"This combination of three antiretroviral drugs inhibits HIV replication by blocking reverse transcriptase and integrase enzymes, preventing the virus from copying its genetic material and integrating into host cells.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced patients"],"catalyst":""},{"name":"Acetylcysteine 2% solution","genericName":"Acetylcysteine 2% solution","slug":"acetylcysteine-2-solution","phase":"phase_1","mechanism":"N-acetylcysteine is a mucolytic agent that works by breaking disulfide bonds in mucus","indications":["Treatment of acetaminophen overdose","Mucolytic therapy for cystic fibrosis"],"catalyst":""},{"name":"Acetylcystine","genericName":"Acetylcystine","slug":"acetylcystine","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Adalimumab, solution for injection","genericName":"Adalimumab, solution for injection","slug":"adalimumab-solution-for-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Adefor dipivoxil","genericName":"Adefor dipivoxil","slug":"adefor-dipivoxil","phase":"marketed","mechanism":"Adeforvir dipivoxil is a nucleotide reverse transcriptase inhibitor that blocks viral replication in hepatitis B by inhibiting the reverse transcriptase enzyme.","indications":["Chronic hepatitis B infection"],"catalyst":""},{"name":"Adefovir tablets","genericName":"Adefovir tablets","slug":"adefovir-tablets","phase":"phase_2","mechanism":"Adefovir works by inhibiting the replication of the hepatitis B virus.","indications":["Chronic hepatitis B","Hepatitis B virus infection"],"catalyst":""},{"name":"Adjuvanted RSVPreF3 vaccine","genericName":"Adjuvanted RSVPreF3 vaccine","slug":"adjuvanted-rsvpref3-vaccine","phase":"phase_2","mechanism":"RSVPreF3 is a recombinant respiratory syncytial virus (RSV) fusion (F) protein vaccine designed to elicit protective immune responses against RSV infection.","indications":["Prevention of respiratory syncytial virus (RSV) disease in adults"],"catalyst":""},{"name":"Adjuvanted pandemic influenza candidate vaccine","genericName":"Adjuvanted pandemic influenza candidate vaccine","slug":"adjuvanted-pandemic-influenza-candidate-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to recognize and respond to pandemic influenza virus antigens, with an adjuvant component to enhance the immune response.","indications":["Pandemic influenza prevention in adults"],"catalyst":""},{"name":"Afuresertib GC - Fasted State","genericName":"Afuresertib GC - Fasted State","slug":"afuresertib-gc-fasted-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Afuresertib GC - Fed State","genericName":"Afuresertib GC - Fed State","slug":"afuresertib-gc-fed-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Afuresertib HPMC capsule - Fasted State","genericName":"Afuresertib HPMC capsule - Fasted State","slug":"afuresertib-hpmc-capsule-fasted-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Afuresertib HPMC capsule - Fed State","genericName":"Afuresertib HPMC capsule - Fed State","slug":"afuresertib-hpmc-capsule-fed-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aimmugen™","genericName":"Aimmugen™","slug":"aimmugen","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Albiglutide 50 mg","genericName":"Albiglutide 50 mg","slug":"albiglutide-50-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Albiglutide 50mg","genericName":"Albiglutide 50mg","slug":"albiglutide-50mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Albiglutide Lyophilized DCC Pen Injector","genericName":"Albiglutide Lyophilized DCC Pen Injector","slug":"albiglutide-lyophilized-dcc-pen-injector","phase":"phase_1","mechanism":"GLP-1 receptor agonist","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Albiglutide liquid auto-injector","genericName":"Albiglutide liquid auto-injector","slug":"albiglutide-liquid-auto-injector","phase":"phase_3","mechanism":"Albiglutide is a GLP-1 receptor agonist that mimics glucagon-like peptide-1 to stimulate insulin secretion and lower blood glucose in patients with type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Albiglutide weekly injection","genericName":"Albiglutide weekly injection","slug":"albiglutide-weekly-injection","phase":"phase_2","mechanism":"GLP-1 receptor agonist","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Albuterol/salbutamol","genericName":"Albuterol/salbutamol","slug":"albuterol-salbutamol","phase":"marketed","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Acute bronchospasm and reversible airway obstruction in asthma","Chronic obstructive pulmonary disease (COPD) with reversible airway obstruction","Exercise-induced bronchoconstriction prevention"],"catalyst":""},{"name":"Albuterol/salbutamol MDI","genericName":"Albuterol/salbutamol MDI","slug":"albuterol-salbutamol-mdi","phase":"marketed","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing rapid relaxation and bronchodilation.","indications":["Acute bronchospasm and reversible airway obstruction in asthma","Chronic obstructive pulmonary disease (COPD) with reversible airway obstruction","Exercise-induced bronchoconstriction prevention"],"catalyst":""},{"name":"Albuterol/salbutamol MDIs","genericName":"Albuterol/salbutamol MDIs","slug":"albuterol-salbutamol-mdis","phase":"marketed","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing rapid relaxation and bronchodilation.","indications":["Acute bronchospasm relief in asthma","Chronic obstructive pulmonary disease (COPD) symptom relief","Exercise-induced bronchoconstriction prevention"],"catalyst":""},{"name":"Alclometasone dipropionate cream","genericName":"Alclometasone dipropionate cream","slug":"alclometasone-dipropionate-cream","phase":"phase_2","mechanism":"Alclometasone dipropionate is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)"],"catalyst":""},{"name":"AltSonflex1-2-3","genericName":"AltSonflex1-2-3","slug":"altsonflex1-2-3","phase":"phase_2","mechanism":"AltSonflex1-2-3 is a small molecule that modulates the sonic hedgehog signaling pathway.","indications":["Metastatic basal cell carcinoma"],"catalyst":""},{"name":"Amlodipine 5 or 10 mg(oral)","genericName":"Amlodipine 5 or 10 mg(oral)","slug":"amlodipine-5-or-10-mg-oral","phase":"marketed","mechanism":"Amlodipine blocks calcium channels in vascular smooth muscle and cardiac tissue, causing vasodilation and reduced blood pressure.","indications":["Hypertension","Chronic stable angina","Vasospastic angina (Prinzmetal's angina)"],"catalyst":""},{"name":"Amoxicillin and clavulanate","genericName":"Amoxicillin and clavulanate","slug":"amoxicillin-and-clavulanate","phase":"marketed","mechanism":"Amoxicillin and Clavulanate Potassium is an antibacterial drug.","indications":["Lower Respiratory Tract Infections","Acute Bacterial Otitis Media","Sinusitis","Skin and Skin Structure Infections","Urinary Tract Infections"],"catalyst":""},{"name":"Antara (fenofibrate) + Lovaza","genericName":"Antara (fenofibrate) + Lovaza","slug":"antara-fenofibrate-lovaza","phase":"marketed","mechanism":"This combination uses fenofibrate to activate PPARα and reduce triglycerides, while omega-3 fatty acids from Lovaza further lower triglycerides and reduce cardiovascular risk.","indications":["Hypertriglyceridemia (elevated triglycerides)","Dyslipidemia in patients requiring combination lipid-lowering therapy"],"catalyst":""},{"name":"Anticancer therapy 3","genericName":"Anticancer therapy 3","slug":"anticancer-therapy-3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Anticholinergics","genericName":"Anticholinergics","slug":"anticholinergics","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Arnuity","genericName":"Arnuity","slug":"arnuity","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Artemether + Lumefantrine","genericName":"Artemether + Lumefantrine","slug":"artemether-lumefantrine","phase":"marketed","mechanism":"Artemether and lumefantrine work synergistically to kill malaria parasites by disrupting their hemoglobin metabolism and causing oxidative damage.","indications":["Uncomplicated malaria caused by Plasmodium falciparum","Malaria caused by Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae (in combination therapy)"],"catalyst":""},{"name":"Arzerra","genericName":"Arzerra","slug":"arzerra","phase":"marketed","mechanism":"B-lymphocyte antigen CD20","indications":["Chronic lymphoid leukemia, disease","Relapsing multiple sclerosis","Secondary progressive multiple sclerosis"],"catalyst":""},{"name":"Augmentin (ES)-600","genericName":"Augmentin (ES)-600","slug":"augmentin-es-600","phase":"marketed","mechanism":"Augmentin ES-600 is a combination antibiotic that inhibits bacterial cell wall synthesis by blocking penicillin-binding proteins, with enhanced coverage against beta-lactamase-producing organisms.","indications":["Acute otitis media in pediatric patients","Sinusitis","Community-acquired pneumonia","Urinary tract infections","Skin and soft tissue infections"],"catalyst":""},{"name":"Avamys aqueous nasal spray 110mcg","genericName":"Avamys aqueous nasal spray 110mcg","slug":"avamys-aqueous-nasal-spray-110mcg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Avandia","genericName":"Avandia","slug":"avandia","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Avodart","genericName":"Avodart","slug":"avodart","phase":"marketed","mechanism":"3-oxo-5-alpha-steroid 4-dehydrogenase 1, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, Glycine receptor subunit alpha-1","indications":["Benign prostatic hyperplasia"],"catalyst":""},{"name":"BOOSTRIX","genericName":"BOOSTRIX","slug":"boostrix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BRL29060A","genericName":"BRL29060A","slug":"brl29060a","phase":"phase_3","mechanism":"BRL29060A is a leukotriene receptor antagonist that blocks cysteinyl leukotriene receptors to reduce inflammatory responses.","indications":["Asthma"],"catalyst":""},{"name":"BW430C (lamotrigine)","genericName":"BW430C (lamotrigine)","slug":"bw430c-lamotrigine","phase":"phase_3","mechanism":"Lamotrigine blocks voltage-gated sodium channels and inhibits glutamate release, reducing neuronal excitability.","indications":["Epilepsy (adjunctive therapy for partial seizures)","Bipolar disorder (maintenance treatment of bipolar I disorder)"],"catalyst":""},{"name":"Belantamab mafodotin frozen liquid","genericName":"Belantamab mafodotin frozen liquid","slug":"belantamab-mafodotin-frozen-liquid","phase":"phase_2","mechanism":"Belantamab mafodotin is a monoclonal antibody-drug conjugate that targets BCMA.","indications":["Multiple myeloma"],"catalyst":""},{"name":"Belantamab mafodotin lyophilized powder","genericName":"Belantamab mafodotin lyophilized powder","slug":"belantamab-mafodotin-lyophilized-powder","phase":"phase_2","mechanism":"Monoclonal antibody targeting BCMA","indications":["Multiple myeloma"],"catalyst":""},{"name":"Belimumab (GSK1550188)","genericName":"Belimumab (GSK1550188)","slug":"belimumab-gsk1550188","phase":"marketed","mechanism":"Belimumab is a monoclonal antibody that inhibits B-lymphocyte stimulator (BLyS), reducing B cell proliferation and autoantibody production in systemic lupus erythematosus.","indications":["Systemic lupus erythematosus (SLE) with active disease","Lupus nephritis"],"catalyst":""},{"name":"Benzoyl peroxide 3%","genericName":"Benzoyl peroxide 3%","slug":"benzoyl-peroxide-3","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Beta-blockers including Carvedilol","genericName":"Beta-blockers including Carvedilol","slug":"beta-blockers-including-carvedilol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Betamethasone valerate 0.1%","genericName":"Betamethasone valerate 0.1%","slug":"betamethasone-valerate-0-1","phase":"phase_3","mechanism":"Betamethasone valerate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)","Lichen planus","Lichen sclerosus"],"catalyst":""},{"name":"Blujepa","genericName":"GEPOTIDACIN","slug":"gepotidacin","phase":"marketed","mechanism":"Blujepa works by inhibiting bacterial DNA polymerase, preventing the replication of bacterial DNA and ultimately leading to bacterial cell death.","indications":["Uncomplicated urinary tract infections","Uncomplicated urogenital gonorrhea"],"catalyst":""},{"name":"Boosted Protease Inhibitor","genericName":"Boosted Protease Inhibitor","slug":"boosted-protease-inhibitor","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Boostrix PolioTM","genericName":"Boostrix PolioTM","slug":"boostrix-poliotm","phase":"phase_3","mechanism":"Boostrix Polio is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","indications":["Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis in adolescents and adults"],"catalyst":""},{"name":"Boostrix TM","genericName":"Boostrix TM","slug":"boostrix-tm","phase":"marketed","mechanism":"Boostrix is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.","indications":["Booster vaccination against diphtheria, tetanus, and pertussis in adolescents (10 years and older) and adults","Pertussis protection in pregnant women (to provide passive immunity to infants)"],"catalyst":""},{"name":"Boostrix-ex-US","genericName":"Boostrix-ex-US","slug":"boostrix-ex-us","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Boostrix™-US formulation","genericName":"Boostrix™-US formulation","slug":"boostrix-us-formulation","phase":"marketed","mechanism":"Boostrix is a vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.","indications":["Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults aged 10 years and older"],"catalyst":""},{"name":"Botulinum toxin A (GSK1358820)","genericName":"Botulinum toxin A (GSK1358820)","slug":"botulinum-toxin-a-gsk1358820","phase":"phase_3","mechanism":"Botulinum toxin A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Hemifacial spasm","Chronic migraine","Spasticity"],"catalyst":""},{"name":"Brevicon","genericName":"Brevicon","slug":"brevicon","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CCB use","genericName":"CCB use","slug":"ccb-use","phase":"phase_2","mechanism":"CCBs work by inhibiting the L-type calcium channels in the heart and vascular smooth muscle, leading to vasodilation and reduced cardiac workload.","indications":["Hypertension","Angina pectoris"],"catalyst":""},{"name":"CCK (Kinevac)","genericName":"CCK (Kinevac)","slug":"cck-kinevac","phase":"marketed","mechanism":"CCK (cholecystokinin) is a synthetic peptide hormone that binds to CCK receptors to stimulate gallbladder contraction and pancreatic secretion.","indications":["Diagnostic agent for assessment of gallbladder function and biliary dyskinesia","Stimulation of pancreatic secretion for diagnostic pancreatic function testing"],"catalyst":""},{"name":"CLDM 1% gel","genericName":"CLDM 1% gel","slug":"cldm-1-gel","phase":"marketed","mechanism":"Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","indications":["Acne vulgaris","Bacterial skin infections"],"catalyst":""},{"name":"CLDM 1% gel twice daily","genericName":"CLDM 1% gel twice daily","slug":"cldm-1-gel-twice-daily","phase":"phase_3","mechanism":"Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","indications":["Acne vulgaris (topical treatment)","Bacterial skin infections"],"catalyst":""},{"name":"COPD rescue medications","genericName":"COPD rescue medications","slug":"copd-rescue-medications","phase":"marketed","mechanism":"COPD rescue medications are short-acting beta-2 agonists (SABAs) that rapidly relax airway smooth muscle to provide quick relief of acute bronchospasm and breathing difficulty.","indications":["Acute bronchospasm relief in chronic obstructive pulmonary disease (COPD)","Rescue therapy for acute dyspnea and airway obstruction in COPD patients"],"catalyst":""},{"name":"CV0601 mRNA COVID-19 Vaccine","genericName":"CV0601 mRNA COVID-19 Vaccine","slug":"cv0601-mrna-covid-19-vaccine","phase":"phase_2","mechanism":"CV0601 mRNA COVID-19 Vaccine works by instructing cells to produce a piece of the SARS-CoV-2 virus, prompting an immune response.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2 virus"],"catalyst":""},{"name":"Candesartan Cilexetil in formulation 1","genericName":"Candesartan Cilexetil in formulation 1","slug":"candesartan-cilexetil-in-formulation-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Candidate Plasmodium falciparum malaria vaccine","genericName":"Candidate Plasmodium falciparum malaria vaccine","slug":"candidate-plasmodium-falciparum-malaria-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to recognize and attack Plasmodium falciparum parasites, primarily targeting the parasite's pre-erythrocytic and blood-stage antigens to prevent malaria infection and disease.","indications":["Plasmodium falciparum malaria prevention in endemic populations","Malaria prevention in children and infants in sub-Saharan Africa"],"catalyst":""},{"name":"Candidate varicella vaccine","genericName":"Candidate varicella vaccine","slug":"candidate-varicella-vaccine","phase":"phase_3","mechanism":"A live attenuated varicella-zoster virus vaccine that stimulates immune responses to prevent chickenpox and herpes zoster infection.","indications":["Prevention of varicella (chickenpox)","Prevention of herpes zoster (shingles)"],"catalyst":""},{"name":"Capoten","genericName":"Capoten","slug":"capoten","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Capozide","genericName":"Capozide","slug":"capozide","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Carvedilol Phosphate modified release formulation","genericName":"Carvedilol Phosphate modified release formulation","slug":"carvedilol-phosphate-modified-release-formulation","phase":"phase_3","mechanism":"Carvedilol is a non-selective beta-adrenergic receptor antagonist with alpha-1 blocking activity that reduces heart rate, blood pressure, and cardiac workload.","indications":["Hypertension","Heart failure with reduced ejection fraction","Left ventricular dysfunction post-myocardial infarction","Angina pectoris"],"catalyst":""},{"name":"Carvedilol extended release only","genericName":"Carvedilol extended release only","slug":"carvedilol-extended-release-only","phase":"phase_2","mechanism":"Carvedilol extended release is a beta-blocker that works by blocking the effects of the hormone epinephrine, also known as adrenaline, and by slowing the heart rate and reducing its workload.","indications":["Hypertension","Heart failure"],"catalyst":""},{"name":"Cell-culture rabies vaccine","genericName":"Cell-culture rabies vaccine","slug":"cell-culture-rabies-vaccine","phase":"phase_3","mechanism":"A cell-culture derived rabies vaccine that stimulates the immune system to produce antibodies and cellular immunity against rabies virus.","indications":["Rabies post-exposure prophylaxis","Rabies pre-exposure prophylaxis"],"catalyst":""},{"name":"Cervarix TM","genericName":"Cervarix TM","slug":"cervarix-tm","phase":"phase_3","mechanism":"Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.","indications":["Prevention of cervical cancer caused by HPV types 16 and 18","Prevention of cervical intraepithelial neoplasia (CIN) grades 1, 2, and 3 caused by HPV types 16 and 18"],"catalyst":""},{"name":"Cervarix vaccine","genericName":"Cervarix vaccine","slug":"cervarix-vaccine","phase":"phase_2","mechanism":"Induces immune response against human papillomavirus (HPV) types 16 and 18","indications":["Prevention of cervical cancer caused by HPV types 16 and 18"],"catalyst":""},{"name":"CervarixTM (GSK580299)","genericName":"CervarixTM (GSK580299)","slug":"cervarixtm-gsk580299","phase":"phase_3","mechanism":"Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, which cause cervical cancer.","indications":["Prevention of cervical cancer caused by HPV types 16 and 18","Prevention of cervical intraepithelial neoplasia (CIN) grades 1, 2, and 3 caused by HPV types 16 and 18"],"catalyst":""},{"name":"Cetirizine Dry Syrup","genericName":"Cetirizine Dry Syrup","slug":"cetirizine-dry-syrup","phase":"phase_3","mechanism":"Cetirizine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses.","indications":["Allergic rhinitis","Chronic urticaria","Allergic conjunctivitis"],"catalyst":""},{"name":"ChapStick Moisturizer, Classic Flavor","genericName":"ChapStick Moisturizer, Classic Flavor","slug":"chapstick-moisturizer-classic-flavor","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Chinese DT vaccine","genericName":"Chinese DT vaccine","slug":"chinese-dt-vaccine","phase":"phase_3","mechanism":"The Chinese DT vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria and tetanus toxins.","indications":["Prevention of diphtheria and tetanus in pediatric and adult populations"],"catalyst":""},{"name":"Chlorhexidine Digluconate Mouthwash with Alcohol","genericName":"Chlorhexidine Digluconate Mouthwash with Alcohol","slug":"chlorhexidine-digluconate-mouthwash-with-alcohol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Chlorhexidine Digluconate Mouthwash without Alcohol","genericName":"Chlorhexidine Digluconate Mouthwash without Alcohol","slug":"chlorhexidine-digluconate-mouthwash-without-alcohol","phase":"marketed","mechanism":"Chlorhexidine digluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, killing or inhibiting growth of oral microorganisms.","indications":["Prevention and treatment of gingivitis","Reduction of plaque formation","Oral antisepsis and antimicrobial rinse"],"catalyst":""},{"name":"Chloroquine, Tafenoquine","genericName":"Chloroquine, Tafenoquine","slug":"chloroquine-tafenoquine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Clindamycin + BPO","genericName":"Clindamycin + BPO","slug":"clindamycin-bpo","phase":"marketed","mechanism":"Clindamycin kills acne-causing bacteria while benzoyl peroxide reduces sebum production and provides antimicrobial activity, together reducing inflammatory and comedonal acne.","indications":["Acne vulgaris (inflammatory and comedonal)"],"catalyst":""},{"name":"Clobetasone Butyrate 0.05% Cream","genericName":"Clobetasone Butyrate 0.05% Cream","slug":"clobetasone-butyrate-0-05-cream","phase":"phase_3","mechanism":"Clobetasone butyrate is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, dermatitis, psoriasis)"],"catalyst":""},{"name":"Co-Codamol","genericName":"Co-Codamol","slug":"co-codamol","phase":"phase_2","mechanism":"Acts as a weak agonist at the mu-opioid receptor and a weak antagonist at the kappa-opioid receptor.","indications":["Pain relief"],"catalyst":""},{"name":"Colgate Cavity Protection","genericName":"Colgate Cavity Protection","slug":"colgate-cavity-protection","phase":"marketed","mechanism":"Colgate Cavity Protection uses fluoride to strengthen tooth enamel and prevent dental caries by remineralizing early enamel damage and inhibiting bacterial acid production.","indications":["Cavity prevention and caries prophylaxis"],"catalyst":""},{"name":"Combined Hepatitis A and B vaccine","genericName":"Combined Hepatitis A and B vaccine","slug":"combined-hepatitis-a-and-b-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies against hepatitis A and B viruses by presenting inactivated viral antigens.","indications":["Prevention of hepatitis A infection","Prevention of hepatitis B infection"],"catalyst":""},{"name":"Combined diphtheria, tetanus, acellular pertussis vaccine","genericName":"Combined diphtheria, tetanus, acellular pertussis vaccine","slug":"combined-diphtheria-tetanus-acellular-pertussis-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Control - UFH","genericName":"Control - UFH","slug":"control-ufh","phase":"phase_3","mechanism":"Unfractionated heparin (UFH) is an anticoagulant that inhibits multiple clotting factors to prevent blood clot formation.","indications":["Acute venous thromboembolism (DVT/PE) treatment and prevention","Acute coronary syndrome","Atrial fibrillation with thromboembolism risk","Cardiopulmonary bypass anticoagulation"],"catalyst":""},{"name":"Control vaccine with the adjuvant system.","genericName":"Control vaccine with the adjuvant system.","slug":"control-vaccine-with-the-adjuvant-system","phase":"phase_2","mechanism":"This vaccine works by stimulating the body's immune system to produce a specific response against a target antigen.","indications":["Prevention of COVID-19"],"catalyst":""},{"name":"Coumadin","genericName":"Coumadin","slug":"coumadin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cumulative corticosteroid exposure","genericName":"Cumulative corticosteroid exposure","slug":"cumulative-corticosteroid-exposure","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DTPa-HBV-IPV (Infanrix penta™)","genericName":"DTPa-HBV-IPV (Infanrix penta™)","slug":"dtpa-hbv-ipv-infanrix-penta","phase":"phase_3","mechanism":"DTPa-HBV-IPV is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, hepatitis B, and poliomyelitis.","indications":["Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and poliomyelitis in infants and children"],"catalyst":""},{"name":"DTPa-HBV-IPV/Hib","genericName":"DTPa-HBV-IPV/Hib","slug":"dtpa-hbv-ipv-hib","phase":"marketed","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"DTPa-HBV-IPV/Hib vaccine","genericName":"DTPa-HBV-IPV/Hib vaccine","slug":"dtpa-hbv-ipv-hib-vaccine","phase":"phase_3","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"DTPa-IPV","genericName":"DTPa-IPV","slug":"dtpa-ipv","phase":"phase_3","mechanism":"DTPa-IPV is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and poliovirus.","indications":["Primary immunization against diphtheria, tetanus, pertussis, and poliomyelitis in infants and children","Booster immunization in childhood"],"catalyst":""},{"name":"DTPa-IPV/Hib vaccine","genericName":"DTPa-IPV/Hib vaccine","slug":"dtpa-ipv-hib-vaccine","phase":"phase_3","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"DTPw-HBV/Hib","genericName":"DTPw-HBV/Hib","slug":"dtpw-hbv-hib","phase":"phase_3","mechanism":"DTPw-HBV/Hib is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b.","indications":["Primary immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"DTPw-HBV/Hib Kft vaccine GSK323527A","genericName":"DTPw-HBV/Hib Kft vaccine GSK323527A","slug":"dtpw-hbv-hib-kft-vaccine-gsk323527a","phase":"phase_3","mechanism":"This combination vaccine stimulates immune responses against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b through inactivated antigens and recombinant proteins.","indications":["Active immunization against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b in infants and young children"],"catalyst":""},{"name":"DTPw-HBV/Hib-MenAC conjugate vaccine","genericName":"DTPw-HBV/Hib-MenAC conjugate vaccine","slug":"dtpw-hbv-hib-menac-conjugate-vaccine","phase":"phase_3","mechanism":"This combination vaccine stimulates immune responses against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, and Neisseria meningitidis serogroups A and C through conjugate technology.","indications":["Prevention of diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, and Neisseria meningitidis serogroups A and C in infants and children"],"catalyst":""},{"name":"DTaP5-HBV-IPV-Hib","genericName":"DTaP5-HBV-IPV-Hib","slug":"dtap5-hbv-ipv-hib","phase":"marketed","mechanism":"This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b.","indications":["Active immunization against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b in infants and children"],"catalyst":""},{"name":"Daprodustat (GSK1278863)","genericName":"Daprodustat (GSK1278863)","slug":"daprodustat-gsk1278863","phase":"phase_3","mechanism":"Daprodustat inhibits hypoxia-inducible factor prolyl hydroxylase (HIF-PH), stabilizing HIF and increasing endogenous erythropoietin production to treat anemia.","indications":["Anemia of chronic kidney disease","Anemia in patients with chronic kidney disease not on dialysis"],"catalyst":""},{"name":"Daprodustat large","genericName":"Daprodustat large","slug":"daprodustat-large","phase":"phase_3","mechanism":"Daprodustat is a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that stabilizes HIF to increase endogenous erythropoietin production and boost red blood cell formation.","indications":["Anemia of chronic kidney disease in patients on dialysis","Anemia of chronic kidney disease in non-dialysis patients"],"catalyst":""},{"name":"Daprodustat small","genericName":"Daprodustat small","slug":"daprodustat-small","phase":"phase_3","mechanism":"Daprodustat is a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that stabilizes HIF to increase endogenous erythropoietin production and boost red blood cell formation.","indications":["Anemia of chronic kidney disease in patients not on dialysis","Anemia of chronic kidney disease in patients on dialysis"],"catalyst":""},{"name":"Daprodustat tablets","genericName":"Daprodustat tablets","slug":"daprodustat-tablets","phase":"phase_3","mechanism":"Daprodustat is a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that stimulates endogenous erythropoietin production to treat anemia.","indications":["Anemia in chronic kidney disease (CKD) patients on dialysis","Anemia in chronic kidney disease patients not on dialysis"],"catalyst":""},{"name":"Decavac™","genericName":"Decavac™","slug":"decavac","phase":"phase_3","mechanism":"Decavac is a recombinant vaccine designed to boost immune response against diphtheria, tetanus, and pertussis by providing booster immunization in adolescents and adults.","indications":["Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults"],"catalyst":""},{"name":"Delayed combination therapy","genericName":"Delayed combination therapy","slug":"delayed-combination-therapy","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Depemokimab (GSK3511294)","genericName":"Depemokimab (GSK3511294)","slug":"depemokimab-gsk3511294","phase":"phase_3","mechanism":"Depemokimab is a monoclonal antibody that inhibits interleukin-4 receptor alpha (IL-4Rα) to reduce type 2 inflammatory responses.","indications":["Moderate-to-severe atopic dermatitis","Eosinophilic esophagitis"],"catalyst":""},{"name":"Detox-B adjuvant","genericName":"Detox-B adjuvant","slug":"detox-b-adjuvant","phase":"phase_3","mechanism":"Detox-B adjuvant enhances immune response by promoting detoxification pathways and supporting innate immunity.","indications":["Vaccine adjuvant (indication under investigation in phase 3)"],"catalyst":""},{"name":"Diclofenac diethylamine 2.32% gel","genericName":"Diclofenac diethylamine 2.32% gel","slug":"diclofenac-diethylamine-2-32-gel","phase":"phase_3","mechanism":"Diclofenac diethylamine is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application.","indications":["Topical treatment of localized pain and inflammation associated with musculoskeletal conditions (e.g., sprains, strains, osteoarthritis)"],"catalyst":""},{"name":"Disintegrating placebo tamsulosin tablet","genericName":"Disintegrating placebo tamsulosin tablet","slug":"disintegrating-placebo-tamsulosin-tablet","phase":"phase_3","mechanism":"Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms"],"catalyst":""},{"name":"Dose 1 BD","genericName":"Dose 1 BD","slug":"dose-1-bd","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Duac® fixed dose combination gel","genericName":"Duac® fixed dose combination gel","slug":"duac-fixed-dose-combination-gel","phase":"marketed","mechanism":"Duac combines clindamycin (an antibiotic) and benzoyl peroxide (an antimicrobial oxidizing agent) to kill acne-causing bacteria and reduce inflammation.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Duac™Once Daily Gel","genericName":"Duac™Once Daily Gel","slug":"duaconce-daily-gel","phase":"phase_3","mechanism":"Duac combines clindamycin (an antibiotic) and benzoyl peroxide (an antimicrobial oxidizing agent) to reduce acne-causing bacteria and decrease inflammation in acne lesions.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Dutasteride plus tamsulosin","genericName":"Dutasteride plus tamsulosin","slug":"dutasteride-plus-tamsulosin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dutasteride/Tamsulosin","genericName":"Dutasteride/Tamsulosin","slug":"dutasteride-tamsulosin","phase":"marketed","mechanism":"Dutasteride/Tamsulosin combines a 5-alpha reductase inhibitor and an alpha-1 adrenergic antagonist to reduce prostate size and relax urinary tract smooth muscle.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms"],"catalyst":""},{"name":"EXDENSUR","genericName":"DEPEMOKIMAB-ULAA","slug":"depemokimab-ulaa","phase":"marketed","mechanism":"Depemokimab-ulaa binds to IL-5, blocking its interaction with the IL-5 receptor and reducing eosinophil activity.","indications":[],"catalyst":""},{"name":"Eltrombopag oral tablets","genericName":"Eltrombopag oral tablets","slug":"eltrombopag-oral-tablets","phase":"phase_3","mechanism":"Eltrombopag is a thrombopoietin (TPO) receptor agonist that stimulates platelet production by binding to and activating the TPO receptor on bone marrow megakaryocytes.","indications":["Chronic immune thrombocytopenia (ITP)","Thrombocytopenia in patients with chronic hepatitis C","Aplastic anemia"],"catalyst":""},{"name":"Encepur Adults","genericName":"Encepur Adults","slug":"encepur-adults","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Engerix TM","genericName":"Engerix TM","slug":"engerix-tm","phase":"phase_3","mechanism":"Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg).","indications":["Prevention of hepatitis B infection in infants, children, and adults","Post-exposure prophylaxis for hepatitis B"],"catalyst":""},{"name":"Engerix-B Kinder","genericName":"Engerix-B Kinder","slug":"engerix-b-kinder","phase":"marketed","mechanism":"Engerix-B Kinder is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B infection.","indications":["Active immunization against hepatitis B infection in infants and children"],"catalyst":""},{"name":"Engerix-B vaccine","genericName":"Engerix-B vaccine","slug":"engerix-b-vaccine","phase":"marketed","mechanism":"Engerix-B stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B infection in infants, children, and adults","Post-exposure prophylaxis for hepatitis B"],"catalyst":""},{"name":"Engerix-BTM","genericName":"Engerix-BTM","slug":"engerix-btm","phase":"phase_3","mechanism":"Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B infection in infants, children, and adults","Post-exposure prophylaxis for hepatitis B"],"catalyst":""},{"name":"EngerixTM-B","genericName":"EngerixTM-B","slug":"engerixtm-b","phase":"marketed","mechanism":"Engerix-B is a recombinant hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B infection in infants, children, and adults","Post-exposure prophylaxis for hepatitis B"],"catalyst":""},{"name":"Engerix™","genericName":"Engerix™","slug":"engerix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Enoxaparine infusion","genericName":"Enoxaparine infusion","slug":"enoxaparine-infusion","phase":"phase_3","mechanism":"Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa.","indications":["Thromboembolism prophylaxis in surgical patients","Treatment of deep vein thrombosis and pulmonary embolism","Acute coronary syndrome","Prevention of thromboembolic complications in atrial fibrillation"],"catalyst":""},{"name":"Epoetin alfa vials","genericName":"Epoetin alfa vials","slug":"epoetin-alfa-vials","phase":"phase_3","mechanism":"Epoetin alfa is a recombinant erythropoietin that stimulates red blood cell production by binding to erythropoietin receptors on bone marrow progenitor cells.","indications":["Anemia associated with chronic kidney disease","Anemia in cancer patients receiving chemotherapy","Anemia in patients undergoing elective surgery"],"catalyst":""},{"name":"Epoetin beta pegol","genericName":"Epoetin beta pegol","slug":"epoetin-beta-pegol","phase":"phase_3","mechanism":"Epoetin beta pegol is a pegylated erythropoietin analog that stimulates erythropoiesis by binding to and activating the erythropoietin receptor on bone marrow progenitor cells.","indications":["Anemia in patients with chronic kidney disease","Anemia in patients with cancer receiving chemotherapy"],"catalyst":""},{"name":"Exenatide 10microgram","genericName":"Exenatide 10microgram","slug":"exenatide-10microgram","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Exenatide placebo (saline)","genericName":"Exenatide placebo (saline)","slug":"exenatide-placebo-saline","phase":"marketed","mechanism":"This is a placebo (saline injection) with no active pharmacological mechanism.","indications":["Control arm in clinical trials of exenatide for type 2 diabetes"],"catalyst":""},{"name":"Experimental Denture Adhesive","genericName":"Experimental Denture Adhesive","slug":"experimental-denture-adhesive","phase":"phase_3","mechanism":"A denture adhesive formulation that enhances the mechanical retention and seal of dentures to oral tissues.","indications":["Denture retention and stability in edentulous patients"],"catalyst":""},{"name":"Ezogabine/Retigabine IR","genericName":"Ezogabine/Retigabine IR","slug":"ezogabine-retigabine-ir","phase":"marketed","mechanism":"Ezogabine opens voltage-gated potassium channels in neurons, reducing neuronal excitability and seizure activity.","indications":["Partial-onset seizures (adjunctive therapy in adults)"],"catalyst":""},{"name":"FEC75","genericName":"FEC75","slug":"fec75","phase":"phase_2","mechanism":"FEC75 is a chemotherapy regimen that combines 5-fluorouracil, epirubicin, and cyclophosphamide to treat breast cancer.","indications":["Adjuvant treatment of node-positive breast cancer","Treatment of metastatic breast cancer"],"catalyst":""},{"name":"FF","genericName":"FF","slug":"ff","phase":"marketed","mechanism":"FF is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and improves bronchodilation in respiratory disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment"],"catalyst":""},{"name":"FF Inhalation Powder","genericName":"FF Inhalation Powder","slug":"ff-inhalation-powder","phase":"phase_3","mechanism":"FF (fluticasone furoate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"FF nasal spray","genericName":"FF nasal spray","slug":"ff-nasal-spray","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FF via ELLIPTA DPI","genericName":"FF via ELLIPTA DPI","slug":"ff-via-ellipta-dpi","phase":"phase_3","mechanism":"FF (fluticasone furoate) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"FF/GW642444 Inhalation Powder","genericName":"FF/GW642444 Inhalation Powder","slug":"ff-gw642444-inhalation-powder","phase":"phase_3","mechanism":"FF/GW642444 is a dual bronchodilator combining a long-acting beta-2 agonist (formoterol fumarate) and a long-acting muscarinic antagonist (GW642444) to relax airway smooth muscle and improve airflow.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma (in combination with inhaled corticosteroid)"],"catalyst":""},{"name":"FF/UMEC/VI (100/31.25/25) mcg","genericName":"FF/UMEC/VI (100/31.25/25) mcg","slug":"ff-umec-vi-100-31-25-25-mcg","phase":"phase_3","mechanism":"FF/UMEC/VI is a triple-combination inhaled therapy that combines a long-acting beta-2 agonist, a long-acting muscarinic antagonist, and an inhaled corticosteroid to reduce airway inflammation and improve bronchodilation in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/UMEC/VI (100/62.5/25) mcg","genericName":"FF/UMEC/VI (100/62.5/25) mcg","slug":"ff-umec-vi-100-62-5-25-mcg","phase":"phase_3","mechanism":"FF/UMEC/VI is a triple-combination inhaled therapy that combines a long-acting beta-2 agonist, a long-acting muscarinic antagonist, and an inhaled corticosteroid to reduce airway inflammation and improve bronchodilation in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"FF/UMEC/VI (200/31.25/25) mcg","genericName":"FF/UMEC/VI (200/31.25/25) mcg","slug":"ff-umec-vi-200-31-25-25-mcg","phase":"phase_3","mechanism":"FF/UMEC/VI is a triple combination inhaler that relaxes airway smooth muscle and reduces airway inflammation through multiple mechanisms to improve airflow in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/UMEC/VI (200/62.5/25) mcg","genericName":"FF/UMEC/VI (200/62.5/25) mcg","slug":"ff-umec-vi-200-62-5-25-mcg","phase":"phase_3","mechanism":"FF/UMEC/VI is a triple combination inhaler that relaxes airway smooth muscle and reduces airway inflammation through multiple mechanisms to improve breathing in chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/VI (100/25) mcg","genericName":"FF/VI (100/25) mcg","slug":"ff-vi-100-25-mcg","phase":"phase_3","mechanism":"FF/VI is a combination of fluticasone furoate (inhaled corticosteroid) and vilanterol (long-acting beta-2 agonist) that reduces airway inflammation and improves bronchodilation in respiratory disease.","indications":["Asthma maintenance treatment","Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/VI 100/25 Inhalation Powder NDPI","genericName":"FF/VI 100/25 Inhalation Powder NDPI","slug":"ff-vi-100-25-inhalation-powder-ndpi","phase":"phase_3","mechanism":"FF/VI is a combination of fluticasone furoate (inhaled corticosteroid) and vilanterol (long-acting beta-2 agonist) that reduces airway inflammation and improves bronchodilation for chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment"],"catalyst":""},{"name":"FF/VI via ELLIPTA DPI","genericName":"FF/VI via ELLIPTA DPI","slug":"ff-vi-via-ellipta-dpi","phase":"phase_3","mechanism":"FF/VI is a combination of fluticasone furoate (inhaled corticosteroid) and vilanterol (long-acting beta-2 agonist) that reduces airway inflammation and improves bronchodilation for chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance therapy","Asthma maintenance therapy"],"catalyst":""},{"name":"FFNS","genericName":"FFNS","slug":"ffns","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FLIXOTIDE and SERETIDE","genericName":"FLIXOTIDE and SERETIDE","slug":"flixotide-and-seretide","phase":"marketed","mechanism":"FLIXOTIDE (fluticasone propionate) is an inhaled corticosteroid that reduces airway inflammation, while SERETIDE combines fluticasone with salmeterol (a long-acting beta-2 agonist) to provide both anti-inflammatory and bronchodilator effects.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"FLOLAN injection with reformulated diluent","genericName":"FLOLAN injection with reformulated diluent","slug":"flolan-injection-with-reformulated-diluent","phase":"marketed","mechanism":"Epoprostenol (prostacyclin) directly relaxes vascular smooth muscle and inhibits platelet aggregation to reduce pulmonary vascular resistance.","indications":["Pulmonary arterial hypertension (PAH)","Acute pulmonary hypertension during cardiac surgery"],"catalyst":""},{"name":"FLOVENT 250mcg","genericName":"FLOVENT 250mcg","slug":"flovent-250mcg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FLOVENT 500mcg","genericName":"FLOVENT 500mcg","slug":"flovent-500mcg","phase":"marketed","mechanism":"Glucocorticoid receptor (GR)","indications":["Maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older"],"catalyst":""},{"name":"FLU HD vaccine","genericName":"FLU HD vaccine","slug":"flu-hd-vaccine","phase":"phase_3","mechanism":"FLU HD vaccine stimulates a stronger immune response against influenza virus by delivering a higher antigen dose compared to standard-dose flu vaccines.","indications":["Prevention of influenza in adults aged 65 years and older","Prevention of influenza in adults aged 18 years and older (Phase 3 evaluation)"],"catalyst":""},{"name":"FLU-Q-PAN H7N9 Formulation 1","genericName":"FLU-Q-PAN H7N9 Formulation 1","slug":"flu-q-pan-h7n9-formulation-1","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"FLU-Q-PAN H7N9 Formulation 2","genericName":"FLU-Q-PAN H7N9 Formulation 2","slug":"flu-q-pan-h7n9-formulation-2","phase":"phase_2","mechanism":"FLU-Q-PAN H7N9 Formulation 2 is a vaccine designed to protect against H7N9 influenza.","indications":["Protection against H7N9 influenza"],"catalyst":""},{"name":"FLU-Q-PAN H7N9 Formulation 3","genericName":"FLU-Q-PAN H7N9 Formulation 3","slug":"flu-q-pan-h7n9-formulation-3","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"FP 0.05%","genericName":"FP 0.05%","slug":"fp-0-05","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FP 500mcg","genericName":"FP 500mcg","slug":"fp-500mcg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Flu Pandemic mRNA_Dose level 2","genericName":"Flu Pandemic mRNA_Dose level 2","slug":"flu-pandemic-mrna-dose-level-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Flu Pandemic mRNA_Dose level 5","genericName":"Flu Pandemic mRNA_Dose level 5","slug":"flu-pandemic-mrna-dose-level-5","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"FluLavalTM-VB","genericName":"FluLavalTM-VB","slug":"flulavaltm-vb","phase":"phase_3","mechanism":"FluLaval-VB is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"FluLavalTM-YB","genericName":"FluLavalTM-YB","slug":"flulavaltm-yb","phase":"phase_3","mechanism":"FluLaval-YB is a quadrivalent inactivated influenza vaccine that stimulates immune response against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"FluLaval® Quadrivalent","genericName":"FluLaval® Quadrivalent","slug":"flulaval-quadrivalent","phase":"phase_3","mechanism":"FluLaval Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children (6 months and older)"],"catalyst":""},{"name":"Fluarix TM","genericName":"Fluarix TM","slug":"fluarix-tm","phase":"phase_3","mechanism":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children ≥6 months of age"],"catalyst":""},{"name":"Fluarix Tetra Vaccine","genericName":"Fluarix Tetra Vaccine","slug":"fluarix-tetra-vaccine","phase":"marketed","mechanism":"Fluarix Tetra is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.","indications":["Influenza prophylaxis in adults and children ≥6 months of age"],"catalyst":""},{"name":"Fluarix and adjuvanted influenza vaccine","genericName":"Fluarix and adjuvanted influenza vaccine","slug":"fluarix-and-adjuvanted-influenza-vaccine","phase":"phase_2","mechanism":"Fluarix and adjuvanted influenza vaccine works by stimulating the body's immune system to produce antibodies against the influenza virus.","indications":["Prevention of influenza disease caused by influenza A and B viruses in people 6 months of age and older."],"catalyst":""},{"name":"Fluarix vaccine","genericName":"Fluarix vaccine","slug":"fluarix-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Fluarix/Influsplit SSW 2012-2013","genericName":"Fluarix/Influsplit SSW 2012-2013","slug":"fluarix-influsplit-ssw-2012-2013","phase":"phase_3","mechanism":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children ≥6 months of age (2012-2013 season)"],"catalyst":""},{"name":"Fluarix™","genericName":"Fluarix™","slug":"fluarix","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Fluarix™ YB","genericName":"Fluarix™ YB","slug":"fluarix-yb","phase":"phase_3","mechanism":"Fluarix YB is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"Fluarix™/Influsplit SSW®","genericName":"Fluarix™/Influsplit SSW®","slug":"fluarix-influsplit-ssw","phase":"phase_3","mechanism":"Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxON0hmWFJBaGprRmtXVzVmRkhQTmNrd0ZfNFhzNzRNRWxQbHhNMXBIYkxTS0JxamwwSjlfRXFPQjhnTjZJbU9xV0JubXJNdU1iMnVaRXhVU1owRUVxSU41bG9aX0V0QTVYTmxOaG9keldNSFlTS29xTFRiSTRCR3FORks1bXQ4d181TXM5T045ZDhQeXdMaVNNRThsTlB1WFRJWnpMbENEN1JFam9mdjVTNU9wZXNjUE1iSnNjZFhvNUVZNWZwc2RzZERnNlh6V0dKcTFVNU1SQVU?oc=5","date":"2026-04-08","type":"regulatory","source":"TipRanks","summary":"GSK Pharma India Shareholders Approve Appointment of CFO Ronojit Biswas via Postal Ballot - TipRanks","headline":"GSK Pharma India Shareholders Approve Appointment of CFO Ronojit Biswas via Postal Ballot","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNdzl1NXo0c3FSdF9zQkNKeWJoTHBDYUdBbTlUSFlHaWw1UDRBUWZ2cjRhZUxUbTU3YnRhWjY2ZWZEd2pBemU1NnhTbDRsM3Y4cWdUNkI2b1l0QjlfdFlDMWotS0lQdEFRZkhSRWFobm80a2ZHSzFpcXVYc0pYRnRNdWJUOWxvWmFxRHV3cldYVHEyNUwxOHJMNnAyald5dWJaOUYtMks2UVZJY3FuVFdobGdJNk9COXB3SENNbG1hMUN2VWhId2E0a0FuQXRMRUhyYkVUN3Z5SjM?oc=5","date":"2026-04-08","type":"pipeline","source":"Markets Mojo","summary":"Glaxosmithkline Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade - Markets Mojo","headline":"Glaxosmithkline Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOV3FPbHFTLWVscmdVdWlfNDliMWhYQ3NoTGU0ZnhncjUwaFljWHRRTmxGRW9ab1dxUG9jNFVPYi1PYXlNNHY2SUhaNy1iLS1teURvaFZ1VktEQ0lWSWdjaDVFZm5GdS01TUltdlZxZFpXbHdCZTMwY1hoTVVIZE8xOEFQT0E3TXNxRUJ1MDI4aG5PTGV6QXJfMWpCTnNQYUhab3VBRjk4SkdzSFE?oc=5","date":"2026-04-02","type":"pipeline","source":"Yicai Global","summary":"UK's GSK Allies With Shanghai Pharma to Bring Hepatitis B Jab Back to China - Yicai Global","headline":"UK's GSK Allies With Shanghai Pharma to Bring Hepatitis B Jab Back to China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQZF9zbG5WV01meHZ4NDBfZ3VNWnFIeFZqS3E4RGcwSFFTMGlCdFl5WjVab2VNRHRtdTg5VDhkU0Q4cmlXMVpNX2xHTUVGMFVMYldkTGRGejdhalNodU0yckU1OEc3Q1F2XzEwTzIydDZIbWtVbHFGcnFFLWc4S2ZNNkxQZFhJaUNGb0VkWFhEZTAybmNtN0QwRmxaOXVMb0pF?oc=5","date":"2026-03-10","type":"pipeline","source":"Fierce Pharma","summary":"A $21M farewell: Emma Walmsley lands nearly 50% pay hike in final year as GSK chief - Fierce Pharma","headline":"A $21M farewell: Emma Walmsley lands nearly 50% pay hike in final year as GSK chief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQczktRkExNUd4QVFfQm96R2pWYVAyd0JvNFdhZVpZNnNKY0p4TkN1Y0taN1pPaDIxZFFUdWMzQjFWVFQxSEFfUml5SU13OGZFSjZ6OHhRdXF6bEI0dldfamZFZGZjUVdZVi1oRlRzQVVVVWpNMlRyZVhJY090YUdaYVFnbDFyOG9vNmY4V212T1NpWGJzRUJZ?oc=5","date":"2026-02-25","type":"deal","source":"GSK","summary":"GSK enters agreement to acquire 35Pharma Inc. - GSK","headline":"GSK enters agreement to acquire 35Pharma Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNX1BCZVQtNl9XVHZrZF9DZXpoZ3NaZzJpb2E1X0plSXFLalRxT0x6NXUwTE5YRUFfWjhJb3NVLWZFSVpfdFNDTTI5a0tOa1ZZZFMxV0pXTUxLMDRadE1IM081a0htYTR6UlZkR2FoMFo0a0hKZnZMbExGcUdoMjZqUm1hN3M1aWFxck9IWU9jTEZ5WnNneWZ4SFNGa0NMbXdNWlZKS1Axdw?oc=5","date":"2026-02-18","type":"deal","source":"mainebiz.biz","summary":"Jackson Lab forms research collaboration with pharma giant GlaxoSmithKline - mainebiz.biz","headline":"Jackson Lab forms research collaboration with pharma giant GlaxoSmithKline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNY0ZTMVVoVTNwX1VILXpxTnpaNTdNWU4xYnVJQ3ZUXzRWN2FWWGVHZTJsNkxucHl1aXNXR2xBX3FPNkthdGFxX2w4M1J0R2pGWUZPcW5JUlZ2ZnBhSkwzM3piVnVUem9KaTZibHNHdjNqVklSWkpQVElvNEEyOHZKZzU1SHFHTU1fejN0VTVob1RRcW8?oc=5","date":"2026-02-04","type":"pipeline","source":"Pharmaceutical Technology","summary":"GSK’s oncology and HIV drugs drive 7% sales rise in 2025 - Pharmaceutical Technology","headline":"GSK’s oncology and HIV drugs drive 7% sales rise in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPSjJWV0F4Wmp3VVJvclBwaF82azBobzIwNFlwTXByX1hpaWxUY1pnV09XVHItYmdmX1I4MzYxZnJBOFZqRXdKdWxaXzhnQmNYSm9taEpJa0hudXZXS3FPNXBna2xXTmZCVnVzalBlUnBEMGtIeEdSWDVRVG5zTDZnY2p2cDNLWEpEdkNzc1dkaVltOHM?oc=5","date":"2025-12-08","type":"deal","source":"BioSpace","summary":"GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya - BioSpace","headline":"GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOem5ud3gyWk1JUTFENXNoLUtHU3dtZ1JYalZXVzFPR1BmbUpuQ0k4OW52VG5MSGtGMk9uMlQ4Wk9NU05uZmNsU2pxaFQxNGNXMzBtSjAtQVBlN2FPYkdHNmxsOW1adjVjYjFSMkR5QWE4T3NURk9EZVlBckVURU1uM1ZzSkRtOF9NdndTNFpRNDNtblBUZ2paRTJZMUpJZDdMWGF5anhGMThCN1FXSjVUNUtyQTFjZDg5ek5vcWkzdVhNZVhjeWRNVTBiejR5MVhGWHY1UFdPSkZ0WENxTVhZMmVvUQ?oc=5","date":"2025-11-06","type":"earnings","source":"Reuters","summary":"GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth - Reuters","headline":"GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBmaVEtNU1Jc0U0aWtYVFRhTFY1d1lUa2ZWa3RKbG1mSXB0TGozMmF6WUFEUzVQQm9xWjdCOG13WFlHTUFWSk5DVXdKSjk3Z3BHQzlvUjFFTWxRdw?oc=5","date":"2025-09-17","type":"pipeline","source":"BBC","summary":"GSK pledges $30bn US investment as UK's pharma woes deepen - BBC","headline":"GSK pledges $30bn US investment as UK's pharma woes deepen","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-17","type":"pipeline","source":"CNBC","summary":"UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit - CNBC","headline":"UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit","sentiment":"neutral"}],"patents":[],"drugCount":300,"phaseCounts":{"marketed":117,"phase_3":104,"phase_2":47,"phase_1":30,"discontinued":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}